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Abstract
The persistent latent reservoir of long-lived cells carrying integrated HIV DNA is the source
of reinfection upon treatment interruption, and a primary focus for cure research. The reservoir
is difficult to study because these cells are relatively rare or located in tissues that are difficult to
sample. Sequencing proviral DNA in the latent reservoir is an important source of information
about reservoir establishment and persistence, especially from the presence of identical (clonal)
sequences. I evaluated the relationship between select measures of these clonal sequences and
drivers of reservoir persistence, e.g., clonal expansion, by implementing a simulation model
of within-host HIV dynamics in actively and latently infected cells. I implemented a discrete
event simulation in the R package treeswithintrees, with four populations of cells corresponding to active, latent, replenishment and death compartments. To simulate molecular evolution
on the resulting trees, I collapsed branches representing infected cells in a latent state and ran
the program INDELible with parameters calibrated to HIV-1 on a representative env sequence.
I propose a new clonality statistic (pairwise clonality) that can capture the genetic diversity of a
sample with less information loss. I then evaluated the response of two clonality statistics used
in literature (the proportion of identical sequences, Gini coefficient) and my proposed clonality
statistic (number of identical pairwise comparisons) to changes in simulation parameter values
by fitting a General linear Model (GLM). I found that the former clonality statistics were not
as robust as the proposed pairwise clonality score. In addition, there were significant associations between clonality statistics and simulation parameters. Finally, I implemented a particle
filtering method to evaluate non-linear relationships between simulation parameters and the
clonality scores.

Keywords: HIV (Human Immuno-deficiency Virus), Latent Reservoir, Within-Host Evolution, Viral Evolution.
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Lay Abstract
Human Immunodeficiency Virus (HIV) is a disease with significant social and economic
burden without a cure – it is currently manageable through combination Antiretroviral Therapy (cART). However cART is unable to remove viruses that have inserted themselves into
the DNA of host cells (the latent reservoir). The latent reservoir is relatively stable and long
lasting and is a source of re-infection if cART is halted, or otherwise made ineffective. The
latent reservoir is difficult to study in humans for various reasons. Therefore, simulations can
be helpful to study the evolution & dynamics of HIV within a host. I created a simulation
framework “simclone” that can simulate within-host evolution of HIV. Events of evolutionary
significance during the course of an HIV infection were simulated: acute infection, cART initiation and chronic infection. Sequence evolution is conducted on the outputs of HIV infection.
Clonality statistics (i.e. how many sequences in a sample are identical) are used to understand
the latent reservoir, but the commonly used statistics (proportional clonality, GINI coefficient)
have significant drawbacks. I propose the “pairwise clonality” statistic as a response to this
issue. I then analyze the simulation model to see if any parameter values (e.g. infection rate)
are associated with increased clonality scores for each of the metrics. I then implement a particle filtering method to attempt simulation parameter estimation based on clonality score. The
results shown in this work i) provide a framework for simulating within-host evolution that
enables specific hypotheses testing ii) proposes a clonality statistic that has better statistical
properties than existing measures iii) highlights the difficulties in using particle filtering for
parameter estimation.
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Chapter 1
Introduction

1.1

Natural History of HIV Infection

Human Immunodeficiency Virus Type I (HIV) is a retrovirus that has a significant global
burden of disease. Retroviruses are viruses in the family Retroviridae, of which the defining
feature is obligate reverse transcription of the viral RNA genome into DNA, and insertion of
the viral DNA into the host genome (Coffin, 1995; Telesnitsky, 2010). HIV is grouped with
other immunodeficiency viruses (e.g. Simian Immunodeficiency Virus, SIV) in the Lentivirus
virus genus, under the subfamily Orthoretrovirinae (Luciw, 1996).
An estimated 38,000,000 [95% CI: 31,600,000 - 44,500 000] individuals are living with
HIV, with a estimated yearly death toll of 690,000 [95%: CI 500,000 - 970,000] as of 2020
(UNAIDS, 2021). An estimated 1.5 million [95% CI: 1.0 - 2.0 million] individuals are newly
infected each year. It is a disease with severe economic and individual impact. While HIVrelated deaths and new HIV infections have declined yearly since the early 2000’s (UNAIDS,
2021) due to advancements in treatments and increased funding for HIV related programs,
there is currently no practical cure for HIV. Three individuals have been cured of HIV, however
these therapies were extreme in nature and are not practical for widespread use. The patients
that have been cured of HIV had cancers that required a bone marrow transplant, a procedure
1
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that confers significant risk. The patients were transplanted with stem cells from a donor with
the CCR5∆32/∆32 mutation (Gupta et al., 2020; Hsu et al., 2022; Hütter et al., 2009). This
mutation confers protection on the patient by preventing HIV binding to the CCR5 co-receptor
(Ni et al., 2018).
Uncontrolled, progression of HIV infection to Acquired Immunodeficiency Syndrome (AIDS)
can take months to years (T. Schacker, 1996; T. W. Schacker, 1998; UNAIDS, 2021). AIDS
is clinically defined as a 200 CD4+ cells per µL or by occurrence of HIV specific associated
disease (Mandell et al., 1995). There is wide variation in the course of HIV infection, the variation is generally understood to be caused by a combination of host (Fauci, 2008; Goff, 2007)
and viral characteristics (Li et al., 1999, Naif et al., 1999, Cavarelli and Scarlatti, 2009). Patients who progress to AIDS are at a higher risk for opportunistic infections caused by bacteria,
viruses, fungi, and parasites due to the reduced CD4+ T-cell levels (Douek et al., 2003; C. B.
Holmes et al., 2003).

ART
Anti-Retroviral Therapy (ART) for HIV has evolved significantly from its original form. The
earliest class of treatments for managing active HIV infection were Nucleoside Reverse Transcriptase
Inhibitors (NRTI). Both sequential and concurrent application of NRTI class drugs resulted
in the rise of drug resistant genotypes (Schmit et al., 1996). Combination Anti-Retroviral
Therapy (cART), also known as Highly Active Anti-Retroviral Therapy (HAART) is the modern standard for ART. It combines anti-retroviral agents of multiple drug classes to reduce the
risk of drug resistance, which typically results in failure of the treatment (Collier et al., 1996;
D’Aquila, 1996; Staszewski et al., 1996). cART targets at least two distinct molecular targets
in the HIV replication cycle. While statistically likely that resistance to at least one agent in the
cART ‘cocktail’ will occur, multiple drug resistance is unlikely if the therapy regime is adhered
to (Coffin, 1995; Frost and McLean, 1994; Stengel, 2008). It is statistically unlikely that drug
resistance mutations would occur at multiple sites concurrently. The typical cART combina-

1.1. Natural History of HIV Infection

3

tion anti-retroviral agents can be divided by function into six groups: nucleoside-analog reverse
transcriptase inhibitors (NARTIs), non–nucleoside reverse transcriptase inhibitors (NNRTIs),
integrase inhibitors, protease inhibitors (PIs), fusion inhibitors, and co-receptor antagonists
(Arts and Hazuda, 2012). It is important to note ART is not a cure, as the treatment does not
excise integrated HIV sequences in the host genome (Arts and Hazuda, 2012). The significance
of these integrated HIV provirus sequences will be discussed further in detail.

Viral Load and HIV Viremia
Viral Load is a density measure of HIV in peripheral blood (HIV copies/mL) (Fraser et al.,
2007). It can vary between patients, and also within patients over time (Mellors et al., 1996).
After the initial infection, there is a phase of exponential viral replication. At this stage, individuals are likely asymptomatic, but are the most infectious. Over the next several months,
the amount of circulating RNA HIV slowly decays to the set point load. The set point value is
the approximate viral load level of an asymptomatic patient. It can differ significantly between
patients, with up to a 1000 fold difference (de Wolf et al., 1997; Mellors et al., 1996). HIV
viral loads are highly predictive of disease prognosis - higher viral loads are associated with
quicker disease progression; and of transmission direction between transmission pairs - higher
viral loads are typically found in the originating individual of a tranmission pair (de Wolf et al.,
1997; Mellors et al., 1996).
Viremia, the presence of circulating virus in the blood stream, is present soon after primary
infection. For most individuals on ART without drug failure, HIV viral loads decrease significantly, below detectable levels (20 - 40 copies/mL). These low levels provide clinical benefits
to the individual (Palella et al., 1998). HIV proviruses are HIV DNA viral sequences that are
integrated into host genomes. Despite controlling the replication of HIV, there exists a set of
infected cells that contain provirus that can produce replication competent HIV (Finzi et al.,
1997a; Siliciano et al., 2003; Wong et al., 1997,Bruner et al., 2016; Y.-C. Ho et al., 2013).
Transient viremia with plasma viral load of up to 500 copies/mL or “viral blips” can occur
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even when patients adhere to ART (Young et al., 2015). Viral blips are specific situations of
viremia - a sharp, transient increase in virus concentration followed by a decrease to undetectable levels. Sustained plasma viral loads above this threshold are interpreted as drug failure
events (Garcia-Gasco et al., 2008). There are many possibilities for the cause of these blips:
poor drug adherence or absorption; or conditions that lead to increased replication (infection,
or vaccinations) (Günthard et al., 2000; L. Jones and Perelson, 2005; Nettles, 2005). Ramifications of viral blips are not yet clear. Investigations into the relationship between viral blips
and subsequent drug therapy failure are mixed (Günthard et al., 2000; L. Jones and Perelson,
2005; Young et al., 2015). Viral blips could be due to integrated proviral sequences in latent
(memory) CD4+ cells. Reactivation is the basis for small spikes of low level viremia and “viral
blips” (Chun et al., 1997; Finzi et al., 1997b; Siliciano et al., 2003). Low level viremia is not
clinically significant (i.e. no significant difference in disease progression or drug efficacy) for
individuals remaining on ART (Nettles et al., 2005).

Disease Progression
The rate of HIV disease progression after a transmission event can differ between individuals.
Speed of progression is governed by host factors, viral factors, and stochastic processes that
are not well understood (Cavarelli and Scarlatti, 2009; Fauci, 2008; Li et al., 1999; Naif et
al., 1999. There are three distinct stages of HIV infection, however individuals may progress
through these stages at different speeds. The acute infection is the first clinical stage of HIV
infection. This stage is charactertized by a CD4+ cell count per µL ≥ 500. Individuals may
present with viral symptoms in this stage such as fever and rash (Moir et al., 2011). Typical
CD4+ cell counts range from 500-1200 per µL. As a patient’s infection progresses, viral load
increases and CD4+ cell counts further decrease due to the cytotoxic effects of HIV replication
(Davey et al., 1999; Fauci, 2008; T. Schacker, 1996). This chronic stage is characterized by
a CD4+ cell count between 200-499 per µL, and can last for months or years. In the second
stage, the concentration of CD4+ lymphocytes declines. The third clinical stage is character-
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ized by high viral loads, a CD4+ cell count lower than 200 per µL or opportunistic infections
(AIDS) (C. B. Holmes et al., 2003). Individuals with HIV do not necessarily progress to AIDS.
Individuals that have at least 12 years of asymptomatic infection, are termed Long Term NonProgressors (LTNP). Although the end result is the same - long term asymptomatic infection
- the basis for asymptomatic disease control differs. Long term control of HIV infection has
been associated with strong neutralizing antibody response and cell-mediated immunity to HIV
(Grabar et al., 2009; Zanussi et al., 1996). Mutations to HIV that result in a weakly replicating strain can also result in asymptomatic infection (Deacon et al., 1995; Iversen et al., 1995).
Weakly replicating strains can still infect large number of cells in a host, however the viral load
is much lower due to ”attenuated productive viral infection” (Iversen et al., 1995). Although
the virus is under control for a period of time, LTNP’s may eventually progress to symptomatic
infection. For most infected with HIV, HIV-mediated CD4+ T-cell depletion occurs early in
an infection. Immunodeficiency does not present immediately, as there is regeneration of the
CD4+ T-cells resulting in an equilibrium. If the virus is left uncontrolled, this equilibrium
deteriorates over time (A. A. Okoye and Picker, 2013).

1.2

Infection Cycle

The HIV infection cycle can be grouped into six stages. These are: entry; DNA synthesis; integration; transcription; RNA modification, transportation and protein synthesis; and, assembly
and budding. The DNA synthesis and integration stages of the infection cycle in particular are
of evolutionary and clinical significance: the DNA synthesis stage is responsible for the vast
majority of mutations in HIV, and thus immune evasion (Coffin, 2002; Hu and Hughes, 2012;
Takeuchi et al., 1988); and the integration stage is responsible for long term HIV infection (Z.
Wang et al., 2018).
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1. Entry (Receptor Recognition and Binding)
Host cell entry is the requisite first step of the replication cycle. Entry is mediated by the
interaction between the HIV env (envelope) spike protein with a host CD4 receptor (Bosque
et al., 2011; Chan et al., 1997; Douek et al., 2002; Kowalski et al., 1987). The HIV env spike
protein constituent proteins are GP120 and GP41 glycoproteins. The GP120 protein mediates
binding between HIV virions and CD4+ T-cells. Conformational changes in GP120 after the
binding between CD4 and GP120 allow for subsequent co-receptor (CCR5 or CXCR4) binding
(Brower et al., 2009). The CD4 receptor is necessary but not sufficient for HIV entry into a cell:
at least one of the aforementioned co-receptors must be present (Brower et al., 2009; Li et al.,
1999). Co-receptor binding causes surface protein re-arrangement, drawing the host membrane
and viral membrane in close proximity and thus allowing the formation of a membrane fusion
pore (Chan et al., 1997). The viral pore provides an avenue for deposition of virion components
into the cytoplasm (Didigu and Doms, 2012). Importance of env proteins and the CD4 host
receptor to viral entry is a motivating factor for vaccine research focusing on the interactions
between these two proteins (Arts and Hazuda, 2012).

2. DNA Synthesis
RNA from the HIV virion is in the positive single strand form. Reverse Transcriptase (RT)
is responsible for converting RNA to double stranded DNA (Hu and Hughes, 2012). RT is
encoded within the HIV genome. RT starts by creating an RNA-DNA hybrid double strand
using the RNA virion genome as a guide (Coffin, 2002). RNase subsequently degrades the
RNA genome, leaving the single negative sense DNA (Kudesia and Wreghitt, 2009; Sarafianos
et al., 2009). RT then swaps strands and uses the single negative sense DNA as a template to
fill out the positive DNA strand. RT jumping between strands allows for high recombination
frequency (Carr et al., 1996; Hu and Hughes, 2012; Kudesia and Wreghitt, 2009). The low
fidelity of RT and the lack of proof-reading mechanism is the molecular driver for the genetic
diversity found within HIV. RT is an important target for antiviral compounds because of its’
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importance in the life cycle (Arts and Hazuda, 2012; Coffin, 1995; Frost and McLean, 1994).

3. Integration
In the integration step, proviral DNA is inserted into cellular DNA. This is an obligate step.
After HIV RNA is reverse transcribed into DNA, it is bound with proteins to create a preintegration complex (Coffin, 1995; Craigie and Bushman, 2012). This complex contains integrase, cellular DNA and other proteins necessary for successful integration. HIV integration is
similar to other transposition systems found in other pathogens such as bacterium (Kulkosky
et al., 1992). The integration step is permanent – to date there are no successful therapies that
can excise the integrated viruses from host genomes. Current drug therapies for HIV are not
curative, rather, they focus on restricting or reducing the ability for HIV to actively replicate.
Long-lived T-cells with integrated HIV proviral sequences is the genetic basis for long term
infection (Chavez et al., 2015; Z. Wang et al., 2018). Integrated HIV in long-lived memory
T-cells can be transcribed and result in release of active virions months to years after integration (Grabar et al., 2009; Zanussi et al., 1996). Cure efforts are focused on addressing this
integrated virus with differing approaches such as: (i) complete replacement of cells with integrated virus; (ii) excision using gene editing technology such as CRISPR; (iii) “shock and kill”,
which activates cells with integrated virus to allow targeted immune response; and (iv) “block
and lock”, a technique where transcription of integrated HIV provirus is blocked via epigenetic modifications (Ahlenstiel et al., 2020). The importance of integrase in the HIV life cycle
and the role of integrase in creating long-lived sources of HIV re-infection, makes integrase a
useful target for inhibitors (Arts and Hazuda, 2012)).

4. Transcription
The HIV genome contains sites that resemble transcription, activator and enhancer regions.
For example, the long terminal repeats in the HIV genome contain enhancers that bind to transcription factors only found in active CD4+ T-cells. When these CD4+ T-cells transition into
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memory cells, transcription factors (i.e. NF-KB, Sp1 and the TATA-box binding protein (TBP))
are no expressed Dutilleul et al., 2020. Without these factors, the expression of HIV proviruses
is halted, resulting in latent (memory) cells that still contain integrated virus. Transcription and
translation of the HIV DNA hijacks normal host cellular machinery (i.e. RNA polymerase II
for reverse-transcription) (Colin and Van Lint, 2009).

5. RNA modification, Transportation and Protein Synthesis
HIV RNA is necessarily modified before protein synthesis. First the virus requires a 5’ cap
and poly-A-tail (Freed, 2001). Next, as with other RNA viruses, the RNA needs to be spliced
to synthesize proteins, however it needs to remain intact to be packaged into virions (Ferguson
et al., 2002; Freed, 2001). Thus there is a phased expression pattern of HIV patterns with
feedback patterns controlling the expression levels of HIV (Ferguson et al., 2002). Initial
proteins govern RNA transport (R) and transactivation (tat). Other (later) proteins are silenced
through splicing (Tomezsko et al., 2020; S. Wang et al., 2022). One of the first proteins to
be synthesized, tat, increases production of other early proteins. Transport of unspliced HIV
RNA out of the nucleus follows rev binding to env (Pollard and Malim, 1998). It is also a
negative feedback regulator, rev down-regulates the production of early genes that encourage
transcription of HIV mRNA and simultaneously up-regulates the transcription of late proteins
necessary for the continuation of the HIV life cycle) Fisher et al., 1986; Pollard and Malim,
1998. Late proteins include cell surface proteins (env) and caspid proteins (Ferguson et al.,
2002; Freed, 2001).

6. Assembly and Budding
The final stage of the HIV lifecycle is the assembly of all constituent parts of the virion in the
cytoplasm of a host cell. Virion assembly occurs through the random simultaneous joining of
all necessary components – viral proteins, membranes and RNA (Ferguson et al., 2002; Freed,
2001). Assembly of the virion is driven by protein interactions with the viral genome. The
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process of budding is initiated after assembly (Sundquist and Krausslich, 2012). HIV is an
membrane enveloped protein, and as such incorporates host membrane into virion particles
(Go et al., 2017; Zanetti et al., 2006; Zhu et al., 2006). Cellular proteins are also randomly
included, based upon cell membrane proteins located at the point of budding. The high amount
of host proteins incorporated into the virion, especially on the surface provides some degree
of immune evasion (Aloia et al., 1993; Ott, 2008). Immune cells have difficulty recognizing
virions with endogenous surface host proteins. The immature HIV virion is released after the
closure of the bud. The virion matures after release when the protease protein is expressed,
and cleaves the gag poly-protein (Ferguson et al., 2002; Freed, 2001). Only mature virions can
infect other cells.

1.3

Latent Reservoir

Cytotoxic effects of active HIV replication result in short life spans for virion producing HIV
cells (the average half-life is approximately 1 day) (Pollack et al., 2017). HIV infection persists
even while ART completely suppresses active replication. HIV persists in individuals adhering
to ART as integrated proviral sequences. While viral blips do occur, integration events from
these reactivated viruses are unlikely to occur due to ART targetting multiple points in the HIV
lifecycle. Therefore the division of long lived resting CD4+ T cells are likely responsible for
the longevity of infection.
The HIV latent reservoir consists of long-lived resting T-cells with integrated replication
competent proviral HIV DNA (Z. Wang et al., 2018). Less than 5% of cells with integrated proviral HIV DNA are replication competent. The remainder of cells have mutations or deletions
that result in non-functional virus (Wong et al., 1997). Estimates for the size of the latent
reservoir range from 104 - 107 (Zhang et al., 1998). The half-life of cells in the latent reservoir is
approximately 44 months. This half-life estimate translates to a natural decay timeline of over
70 years (Crooks et al., 2015; Finzi et al., 1997a; Siliciano et al., 2003. Cells with integrated
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replication competent HIV can sporadically reactivate, releasing virions. Reactivation is a
process by which cells with integrated dormant provirus are stimulated to produce virions
(Corey et al., 2004; Grabar et al., 2009; Zanussi et al., 1996). Reactivation happens at a
predictable rate, when latent T-cells are activated upon encountering an antigen, or through
indirect activation via an inflammatory process (Corey et al., 2004). Reactivation is a potential
source for reinfection for individuals that do not adhere to an ART regimen or in cases of drug
failure (Arts and Hazuda, 2012). Viral rebound can happen within weeks of drug failure or
cessation (Crowell et al., 2019; Davey et al., 1999). Early models of latent reservoir persistence
suggested that quiescent cells with slow turnover were solely responsible for the longevity and
stability of the reservoir (Y.-C. Ho et al., 2013; Siliciano et al., 2003). This understanding of
the latent reservoir persistence has been challenged by findings that show cellular proliferation
(especially clonal expansion) plays a role maintaining the latent reservoir (Bosque et al., 2011;
Yeh et al., 2021).
Clonal expansion is an adaptive immune process whereby cells that are stimulated by an
antigen proliferate into clones (Adams et al., 2020). Clonal expansion of cells with integrated
pro-viral sequences was shown to contribute to the persistence of the latent reservoir (Maldarelli et al., 2014). Three mechanisms have been identified as contributors to the clonal expansion of infected cells. Firstly, integration of pro-viral sequences in proximity to highly
transcribed regions may promote cellular proliferation, and therefore clonal expansion. HIV
preferentially integrates close to genes that govern cell division (Schröder et al., 2002). Viral
promoter genes may increase the transcription of these genes, thereby promoting cellular proliferation (Maldarelli et al., 2014). The second mechanism that might contribute to clonal expansion of infected cells is homeostatic proliferation. Memory T-cells are maintained through
cellular proliferation as a normal response to cytokines (Schluns and Lefrançois, 2003). Homeostatic proliferation is a non-selective process, whereby a stable T-cell population can be maintained for normal immune function. Homeostatic proliferation of HIV+ T-cells occurs without
re-activation, suggesting this process would not trigger response from the immune system or
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immunotherapies (Bosque et al., 2011). The third mechanism that has been identified is antigenic stimulation due to chronic exposure. Chronic or repeated antigen exposure could stimulate clonal expansion of infected CD4+ T-cells (Douek et al., 2002). In contrary to the clonal
expansion mechanism of latent reservoir persistence, a controversial mechanism is the constant
seeding of the latent reservoir by low levels of ongoing HIV replication in drug sanctuary sites
(C. V. Fletcher et al., 2014). Tissues such as lymph nodes where there is poor drug penetration
may create drug sanctuary sites where active replication of HIV is permissible. This mechanism is contested with studies reporting conflicting results, with proponents citing low latent
reservoir diversity as evidence of ongoing seeding (Barton et al., 2016; Eisele and Siliciano,
2012; Kulpa and Chomont, 2015).
The genetic diversity of the latent reservoir can be quantified using multiple approaches,
each with their own benefits and limitations. Integrated proviruses can be fully sequenced
(albiet missing some nucleotides between the primers) using primers that target conserved regions (Salminen et al., 1995). Only full length coverage guarantees identical sequences are
truly clonal. Sampling short subgenomic regions does not adequately capture the full genetic
diversity of a sample, thus biasing genetic diversity estimates (Laskey et al., 2016; Z. Wang et
al., 2018). Full length sequencing techniques are limited because defective provirus sequences
are included in this sequencing. It is difficult to estimate the viability of integrated provirus
sequences from sequences alone. While HIV preferably integrates into gene promotor regions,
it is not base specific. Therefore the probability of identical integration sites occurring from
two unique integration events is infinitesimally small (Maldarelli et al., 2014; Schröder et al.,
2002). As such, identical integration sites in two sequences is an indicator of clonal expansion.
Approaches that sequence integration sites are important as presence of identical provirus sequences is not necessarily indicative of clonal expansion. For example, it is possible that highly
identical sequences seed the latent reservoir early on in an infection, as in the case of SIV (Spira
et al., 1996). In addition, it is difficult to identify viability of proviral sequences from just integration sites. Most viability analyses are limited to detecting obvious issues such as frame
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shifting mutations (Carrillo et al., 1998; Domingo and Holland, 1997; Maldarelli et al., 2014;
Schröder et al., 2002). These defective or non-viable pro-viral sequences are not part of the latent reservoir, as the latent reservoir only includes replication competent virus. There are new
methods that combine full length sequencing with integration site sequencing, completeness
and replication competency analysis (Patro et al., 2019). This method is a powerful technique
as it allows a previously impossible task - linking integration sites to their source proviral sequences. However, this method is time and resource intensive, and is not suited for large-scale
studies. Regardless of sequencing technique, sequencing errors increase the variation observed
in the viral population, and thereby inflate estimates of the size or the diversity of the latent
reservoir.
The gold standard method for quantifying the latent reservoir is the Viral Outgrowth Assay
(VOA). Sequential serial dilutions and outgrowth stages amplify low levels of infection to
detectable levels. By diluting samples, each ’well’ in the assay receives on average less than
one provirus. In outgrowth stages, samples in wells are cultured with HIV susceptible cells.
Once HIV RNA is amplified to detectable levels, HIV RNA present in outgrowth assays are
sequenced, allowing for quantification of genetic diversity. VOAs allows estimation of number
of infected cells in the latent reservoir, as the dilution factor is known from the serial dilution
step. VOAs are limited by their expensive and time-intensive nature. However, this method
is the only method that can filter cells that contain replication incompetent proviral sequences
(Siliciano et al., 2003; Taswell, 1984).
Regardless of the method used for measuring the viral diversity in the latent reservoir,
summary statistics are needed to report the clonality. Clonality is a measure of the occurrence
of identical genetic sequences in a population (Ferreira et al., 2021; Hosmane et al., 2017;
Joos et al., 2008). A variant (v) in a population is an unique sequence. In literature, there
are two widely used methods of quantifying latent reservoir clonality. First is to calculate
the proportion of sequences that have at least one other identical sequence in the population,
shown in Eq.1.1 (von Stockenstrom et al., 2015; Wagner et al., 2014). For a population with S
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sequences, where each variant has ni individuals, and I(x) is an indicator function that returns
1 if true (i.e. when there is more than one individual in a variant), otherwise 0.

p1 =

Σvi ϵP ni I(ni > 1)
∥S ∥

(1.1)

Second is to calculate the proportion of variants in a population that are non unique (Maldarelli et al., 2014). For a population partitioned by variant, with P partitions.

p2 =

Σvi ϵP I(ni > 1)
∥P∥

(1.2)

In the second method, the clonality score does not report the membership size of a variant
group - it only reports the comparisons between membership groups. To illustrate the difference
between these measures, consider a population with 3 individuals with sequence 1 (variant
1), 2 individuals with sequence 2 (variant 2); and 1 individual with sequence 3 (variant 3)
(S: {v 1: 3, v 2: 2, v 3: 1 }). Depending on which proportional clonality score is used (1.1 or
1.2), the clonality score is effected as the denominators are widely different. p1 (1.1) would
give a clonality score of 5/6, or 0.83; and p2 (1.2)) would give a clonality score of 2/3, or 0.66.
The current methods for describing clonality are not up to the task of accurately describing the
underlying dynamics of the latent reservoir. Among these issues are: existing methods do not
evaluate statistical significance of group membership (Ferreira et al., 2021); and under-estimate
extent of clonality due to under-sampling (Reeves et al., 2017).

1.4

Viral Evolution Within Hosts

Phylogenetics is a wide ranging field of study that attempts to draw biological insights by studying the evolutionary relationships between individuals and populations – a subset of phyloge-
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netics is phylodynamics (Yang and Rannala, 2012). Phylodynamics is the study of epidemiological, immunological, and evolutionary processes that shape viral phylogenies (E. Holmes et
al., 1995). Genetic sequence data is used to infer the underlying process at play – especially in
processes that are hard to study. Transmission dynamics, both within-hosts and between-hosts
can be studied using these methods.
For example, phylogenetics is used to study the discordance between among-host (between
individuals) and within-host (within a single individual) rates of HIV evolution. An order of
magnitude separates the the two types classes of HIV evolution (Lemey, 2005). In a chronically infected individual with uncontrolled HIV, the HIV population is genetically diverse.
The molecular driver for this diversity is Reverse Transcriptase (RT). RT lacks a proofreading
mechanism, and therefore introduces relatively large numbers of mutations, as compared to
DNA/RNA replication (Carr et al., 1996; Hu and Hughes, 2012; Kudesia and Wreghitt, 2009).
A small number or even just an individual virus establishes an infection in an individual. The
sharp decrease in viral diversity between individuals in a transmission pair has been termed
the ”transmission bottleneck” (Bergstrom et al., 1999). To date the causes of this genetic
bottleneck have not been identified. Studies have suggested that the immunological and physiological environment of viral entry points are part of the selection process (Bergstrom et al.,
1999; Boeras et al., 2011). There is a strong selective filter during the transmission bottleneck,
reflected in the high number of exposure events that are required for successful transmission
(E. Holmes et al., 1995; Keele et al., 2008; Rieder et al., 2011; Salazar-Gonzalez et al., 2009;
Shaw and Hunter, 2012). Transmitted/Founder studies have found that shortly after infection
the viral population of a recipient is genetically homogenous regardless of the viral diversity
of the founder individual (Boeras et al., 2011; Gnanakaran et al., 2011).
Within-host evolutionary dynamics are typically thought to be governed by selective forces
and competitive fitness. Whereas between-host evolution is typically thought to be governed by
neutral forces (evolution occurs due to random genetic drift), as multiple types of HIV (i.e. A,
B, D) co-exist on population level. In the context of within-host evolution of viruses, neutral
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mutations are ones that do not effect an the viruses’ potential to transmit. The neutral theory of molecular evolution posits that most mutations are either neutral or slightly deleterious
(Kimura, 1968). Neutral forces are thought to govern within-host evolutionary dynamics due
to lack of evidence of selection (Frost et al., 2018; Frost and Volz, 2013). There is a trade-off
between within-host fitness and population-level (epidemiological) fitness - for example, traits
that confer selective advantage to the virus within a host (e.g. immune adaptation) may reduce
transmission potential (Alizon and Fraser, 2013; Lemey, 2005; Pybus and Rambaut, 2009;
Vrancken et al., 2014). This trade-off has been shown in transmission studies - successful
variants are most often not the predominant variant within the host donor (Joseph et al., 2015;
Shaw and Hunter, 2012). In contrast with other viruses, such as hepatitis C, within-host and
among-host HIV evolution does not differ significantly across the genome (Alizon and Fraser,
2013). For example, hepatitis C has higher rates of evolution in the the envelope genome (Gray
et al., 2011). There are several hypotheses to why there is discordance between the two rates
of HIV evolution. One such hypothesis is that selection pressures differs between stages of infection, with selection pressures and therefore evolution rate reduced in early infection. In this
model, HIV evolves at much quicker rate during the later chronic infection stage. Slower evolution in the initial stages of the infection has been suggested to result from insufficient immune
response (resulting in reduced selective pressures) (Berry et al., 2007). Transmission tends to
occur early in an infection, when viral loads are typically higher. Transmissions that occur
earlier in an infection would tend towards carrying fewer mutations, as each round of viral
replication results in a high number of mutations. Within-host evolution tends to be measured
over a long time horizon in individuals with unsuppressed HIV infections, during the chronic
infection stage. An increased rate of evolution during the chronic infection stage, would result in higher observed evolution rates within-host as compared to between hosts (Berry et al.,
2007; Lythgoe and Fraser, 2012).
The second model hypothesizes that the discordance between rates of evolution results
from HIV becoming adapted to the host’s immune response. However, these mutations only
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increase fitness in a particular host, and quickly revert after transmission. This model suggests
that a high proportion of mutations revert once the virus is transmitted to a new host. Once
again this would result in a mismatch of evolution rates, as only a small number of mutations
would accumulate at the population level (Matthews et al., 2008).
The final model for HIV evolution is the “store and retrieve” hypothesis. In this model,
HIV variants seed the latent reservoir early in the infection. Over time the latent reservoir is
maintained through clonal expansion. Upon reactivation, possibly months to years later, early
archived viral strains are able to circulate once again. It was suggested that these early variants
have higher transmission fitness or remain in anatomical compartments close to routes of transmission - i.e. in the genital tract (Lythgoe and Fraser, 2012; Sagar et al., 2009). As such, these
early variants would be more likely to be transmitted than variants that seed the latent reservoir
later in infection (Lythgoe and Fraser, 2012). Evidence for this model of HIV evolution is
mixed. In support of this model, transmission pair studies have shown that ancestral sequences
are more closely related to actively reproducing/circulating virus in a newly infected individual, as opposed to actively reproducing/circulating virus in the originating individual (Herbeck
et al., 2011; Sagar et al., 2009).
Much about the latent reservoir remains unknown. The mechanism underlying the establishment and persistence of the latent reservoir is still not fully known. ART is able to control
active infection and taken proactively it is able to prevent the establishment of an HIV infection
(A. Okoye et al., 2007). However, current therapies do not address the latent reservoir. Therefore, understanding mechanisms for persistence to prevent initial establishment of the latent
reservoir are important towards the pursuit of a HIV cure.

1.5

Scope of project

The following body of work is divided into three chapters. In Chapter 2, I describe the simclone simulation pipeline I created. In this chapter I show how the HIV-1 within-host dynamics
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are captured using the simclone framework in an existing host-pathogen simulation program.
The methods used to explore the simulation parameter space are detailed. Further, I describe
the nucleotide evolution portion of the pipeline that follows population dynamics simulation. I
present sample inputs and outputs for each simulation step. The mechanism of HIV- 1 latent
reservoir establishment and persistence has previously been modelled using simulation methods (Perelson and Ribeiro, 2013). Modelling has provided insights into immune escape, viral
evolution, impact of treatment, and other topics of research in HIV research. In this chapter I show that the host-pathogen simualtion program twt can be be used to simulate HIV-1
within-host dynamics.
In Chapter 3, I use the simclone simulation pipeline described in Chapter 2 to investigate
methods of calculating clonality. In biological systems, including the HIV-1 latent reservoir,
genetic identicality implies a particular biological mechanism. In the case of the latent reservoir, identicality implies clonal expansion contribrutes to latent reservoir persistence. The
degree to which clonal expansion is responsible for persitence is contested. There are many
ways of calculating the degree of identicality in a population (clonality). The means by which
clonality is calculated can affect downstream correlative analyses. In chapter 3 I attempt to
draw associations between clonaltiy scores and simulation parameters using three calculations
for clonality, two methods used in literature: proportional clonality; and the Gini Index, and a
method I propose ”pairwise clonality”.
In Chapter 4, I attempt to find non-linear associative trends between simclone parameters
and clonality scores. I use particle filtering, a statistical noise reduction technique, to estimate
parameter values from clonality scores. Particle filtering is a method whereby simulation samples (particles) that are poor representations of real values are systematically removed. In my
implementation of particle filtering, particles are given an RMSE score against target simulations. I show that particle filtering cannot be used to predict parameter values for many of the
simclone parameters.
Finally in Chapter 5, I discuss limitations and implications of my research, in particular
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the findings of the clonality score chapter. I also propose future directions based on the work
completed in this thesis.

Chapter 2
Simulation Model (Simclone)
2.1

Introduction

Within host HIV evolution is difficult to study in-vivo for practical and economic reasons.
A non-exhaustive list of practical reasons include: it is difficult to sample tissues where the
latent reservoir resides (i.e. Lymph Nodes and Gut Associated Lymph Tissues (Ahlenstiel
et al., 2020); it is difficult to isolate productive latent reservoir cells due to lack of biomarker,
although recently advances have been made in detection (Darcis et al., 2019); and the relatively
low proportion of cells that constitute the latent reservoir in proportion to circulating non latent
reservoir cells (Siliciano et al., 2003). Expensive and invasive sampling techniques are required
to isolate cells in the latent reservoir due to the aformentioned issues. Simulations of the
dynamics of the latent reservoir has been used to address questions about immune escape,
CD4+ depletion, and viral evolution (D. D. Ho et al., 1995; Perelson and Ribeiro, 2013).
Previous work does not allow individual lineages to be tracked in an infection back to an index
case. Having the simulated transmission, latency, and reactivation events histories can provide
novel information that may motivate experimental or clinical studies. I created the simclone
simulation pipeline to address this gap in simulation programs. Simclone can simulate HIV
within host evolution while also allowing lineages to be tracked.
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Figure 2.1: simclone Framework. Parameters are labelled with [n], with labels found in 2.1.
Some labels are used more than once (e.g. [4,5,6,7]). In the simclone framework transition
parameters are independent of infection status. Encapsulated virus under [1] represents an
HIV Virion.

2.2
2.2.1

Simulation Pipeline and Performance
Simulation Pipeline Overview

The simlone simulation pipeline consists of 3 distinct overarching steps: (1) Creating specification files; (2) Within-host simulation and phylogenetic tree generation; (3) Simulation of
nucleotide evolution. There are several bash and Python scripts that were used to manage the
simclone pipeline. The first step of the simclone pipeline is to create sets for the simulation
model. Parameter combinations were set by establishing bounds that resulted in within-host
dynamics that consistent with modelling in literature (D. D. Ho et al., 1995; Perelson and
Ribeiro, 2013; Wei et al., 1995). Parameter estimates from the peer-reviewed literature were
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used as a starting point, and adapted for the timescale of the simulation model set by computational constraints in step (2). A Python script generates yaml specification files for the
simulation pipeline. The command-line interface can be used to specify options including: the
number of samples generated; and the number of replicates per samples. Optionally, a sample
name can be specified by the user to label an simulation run as desired. This Python script
generates all necessary specification files and directory structures for step (2). An unique specification file is generated for each sample, however replicates share a common specification
file. Next, using an R script, within-host interactions (e.g. transmission between cells) are simulated and transmission trees are generated for each replicate. The main output of interest from
the within host simulations are phylogentic trees that represent the evolutionary history of viral sequences sampled from simulated HIV-1 infections. Following phylogenetic tree creation,
guide trees generated in step (2) are used to simulate nucleotide evolution on a reference HIV-1
env sequence.

2.2.2

trees within trees (twt)

twt is an R package jointly developed and maintained by members of the Poon lab (www.
github.com/poonlab/twt). The program combines forward-time and reverse-time methods to
simulate host-pathogen trees. Forward-time simulations are used to simulate population dynamics, starting from an index case. In forward-time simulations, a Markov state process is
used to simulate the population dynamics of the infection. Markov state processes are random
processes where a future state is independent of past states, and only dependent on the present
state. The probability of an event (transmission and transitions) occuring is drawn from a
joint distribution of rates defined in specification files. The reverse-time simulation method
used in twt is the coalescent, it is used to resolve the transmission and transition history of viral
lineages in sampled cells back to the index case. The coalescent is a model that resolves the ancestral relationship between sampled individuals in a population. Coalescent theory estimates
the time between period between lineages and their ancestral states. Reverse-time methods are
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used for resolving transmission and transition history, as ‘unimportant’ events can be ignored,
thus saving computational effort. The basic unit of the twt framework is a cell. A cell can be
susceptible or infected. Each cell belongs to a class of cells and all cells in a class share a set of
user defined rates that govern its interactions with other cells in the framework, (i.e. infection
rate). In twt, compartments are containers for cells of a singular class, and can contain susceptible and infected cells. It is important to note that in twt a ‘compartment’ is not the same
as a compartment in a physiological sense – a compartment does not represent a spatially or
physically segregated group of cells. Rather, a ‘compartment’ in twt is termed as a group of
cells that share characteristics (to avoid confusion I term a compartment in twt as “cell types”).
There could be compartments in twt in the physiological sense (groups of physically or spatially segregated cells), however these are not implemented in the simclone framework. There
are two type of events that occur at a given rate: transmission – infection of a susceptible cell
by another infected cell; and transition – the transition of a cell from one state to another, (e.g.
from active to latent). An infected cell is always involved in a transmission event. However
transition events do not require a cell to be infected. When a cell transitions between types,
it maintains its infected status. Transmission rates between cells of different classes can be
varied depending on the compartment of the cells in question. When a cell transitions between compartments, it assumes the dynamic characteristics of its new compartment. There
is no theoretical limit to the number of compartments that can be defined, only computational
(memory) limits. As the number of compartments, and the number of individuals within them
increase, computation costs increase as well. Within this program, a number of parameters can
be defined such as the number of compartments, compartment size, transmission rates between
and within compartments, and transition rates between compartments.
The first stage of the simulation process is the forward simulation of the population dynamics of the infection. This forward simulation process is a discrete Markov process. In a
discrete Markov process, the probability of events occuring are dependent on the current state
of a system – independent of previous events. Starting from an index case (i.e. infection starts
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with one cell), the random spread of infection and transition of cells between compartments is
simulated. An assumption of twt is that there can only ever be one cell infected at the start.
If seeded with multiple infected cells, there would not be a single lineage tree that could be
created relating all infected cells in the simulation. Each cell type is initialized with some
number of susceptible cells. For every step in the Markov Chain, transmission and transition
rates govern the movement of cells between cell types, and the infection of susceptible cells by
infected cells.
At user defined sampling times, ni cells are sampled from the ith compartment. It is important to note that Σni ≤ ΣNi ; where Ni is the number of cells in ith compartment and can
vary over time. Using the transmission and transition events in the first step, a transmission
tree from the index case (source) is generated for the sampled cells. A transmission tree is
an hierarchal graph structure (where each node in the tree has only one parent, but may have
one or more children, except the root node which has no parents) that represents the infection
events between cells between the index case and all sampled cells. In this graph, internal nodes
(non tip and non root nodes) are not necessarily sampled, but can are inferred. This transmission tree relates the ancestry of sampled cells from the simulation, and may include unsampled
individuals where necessary. The transmission tree is also called the outer tree in the twt.
From these sampled cells, the Gillespie method (Gillespie, 1976) is used to simulate a transmission tree backwards to the index case. The Gillespie algorithm is a process by which the
occurence of stochastic events is determined by drawing values from an exponentially distribution, scaled to probability rates. Reverse simulation makes it computationally feasible to model
many interactions in complex systems. Reverse simulation increases the computational feasibility because the number of sampled cells is much lower than the number of total cells. Thus
the simulation algorithm does not need to consider as many individuals. Finally a pathogen
tree is simulated by coalescing the viral lineages in the sampled cells to resolve an ancestral
history of the viral lineages to the index case.
In summation, the existing twt program first simulates the population dynamics (how viral

24

Chapter 2. Simulation Model (Simclone)

lineages spread through cell types); resolves the ancestral relationship between sampled cells;
and finally resolves the ancestral lineage of the viruses in the sampled cells.
Further details of how the population dynamics, transmission tree and pathogen tree are
simulated can be found on the twt github repository (see above for repository link).
twt was designed to simulate the dynamics of virus populations being transmitted between
hosts. I extended the twt framework for simulating the dynamics of cells within a single host,
which I call the simclone framework. In the simclone framework (Fig. 2.1) there are four unique
compartments; Active, Latent, Replenishment, and Death. To avoid confusion with “compartment” in the physiological sense, I will now refer to these compartments as cell types. This
nomenclature will also make discussion regarding expansion of the simclone framework easier
to understand. The Active cell type contains cells that can infect other Active or Latent type
cells when infected. Active cell types can transition to the Latent cell type (modelling latency)
or Death cell type (modelling death). Latent cell types can be infected, but cannot infect other
cells. Latent cells can undergo clonal expansion, transition to the Active cell type (modelling
re-activation), or transition to a Death type cell (modelling death). Clonal expansion in the simclone framework is modelled as a transmission event. I assume that “daughter” cells replace an
uninfected cell of the same cell type. The Replenishment type cells cannot be infected, but can
transition to become active or latent type cells. These transition processes mimic cell regeneration/ proliferation. Lastly death type cells can neither be infected nor transition to another
cell type. The death cell type is important for modelling the death of viral lineages in the twt
framework. Without the death cell type, viral lineages would continue to propagate.
Besides the parameters that define the interaction between cells, there are parameters that
govern the sampling time, and simulation length that can be defined as well. The simulation
length is the set period of time that the simulation runs for until sampling events, it is dimensionless and not scaled to real-world equivalents. Epochs are a distinct period of time, within
an epoch transmission and transition rates and fixed. Multiple epochs can exist for a given
simulation. The goal of multiple epochs is to allow for different viral transmission environ-
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ments. For example, in the simclone framework, there are two epochs: an epoch where there
is uncontrolled active transmission; then a second epoch where there is no active transmission.
This is how the simclone framework mimics the initiation of successful ART. To model ART
in the simclone framework, I assume that the Active cells can no longer infect other cells (i.e.
AAbr = 0); in the simclone framework transmission events originating in Active cell types are
no longer allowed. To simplify the model, the simclone framework assumes that all active
infection is halted at the initiation point of ART.

Definable parameters within the simclone framework are described in Table (2.1). As discussed previously, the two epochs represent two phases of a typical HIV-1 patient that initiates
ART. In the first epoch, the 12 parameters in Table (2.1) are fixed to values generated in step
(1) of the simclone pipeline, based on models of the within-host dynamics system (D. D. Ho
et al., 1995; Perelson and Ribeiro, 2013; Wei et al., 1995). The generation of parameter combinations from the above distributions will be discussed further later. At the second epoch, the
transmission rates of Active type cells are set to zero (AA br and AL br). As cells ‘die’ by
transitioning to the death type, active and latent type cells take their virus lineages with them.
The end result is that there is a complete or near-complete removal of all viral lineages from the
Active compartment, which mimics the real-world suppression of HIV-1 replication through
ART. After initial parameter setting testing, some definable twt parameters were fixed to allow
for transmission characteristics parameter response testing. These parameters were: sampling
time (t=10); ART initiation time (t=5), and number of cells sampled per cell type (n=100).

Specification files for twt use the YAML markup language (Ingerson et al., n.d.). The
YAML markup language is a structured language much like XML or HTML, but with a much
simpler syntax. Data can be nested and labelled with the YAML format. The simclone framework is saved as a template YAML file, with string markers (i.e. ”[AA br]”) for modifiable
parameter settings. The templates enable automated specification file generation. An example
YAML specification file can be found in the supplemental section A.1.
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2.2.3

Latin Hypercube Sampling

There are 11 parameters in the simclone framework that need to be varied in order to measure
the responsiveness of clonality statistics to changes in parameter settings. Incremental sampling of parameter setting combinations (i.e. drawing n samples for each of the parameters)
would be an inefficient approach to exploring the simclone parameter space. There are simply
too many parameter combinations (N = n11 ) for robust parameter space testing in a computationally feasible manner. Hence, parameter selection was preformed through Latin Hypercube
Sampling (LHS).
LHS is a method for sampling a multi-dimensional space in a pseudo-random fashion.
Latin Squares in statistics are much like the Sudoku square, in that it is a descrete n by n
square in which a value is not repeated on a vertical nor horizontal axis. The “Hypercube”
portion of the LHS moniker refers to the multiple dimensions that the sampling method is
applied to. There is no theoretical limit to the number of dimensions that the LHS method can
be applied to - however there may be practical limits to this method. The LHS method was
described first by McKay et al., 1979 and expanded further by Iman and Conover, 1982. The
LHS method works by dividing each parameter into k intervals, with each interval of size x/k;
where (xmax − xmin ) is the range of the parameter and k is also the number of samples. One value
is sampled from each of the k intervals. This is repeated n times, drawing k values for each
parameter value. The LHS algorithm then randomly combines the samples across parameters
such that there is a sample in each interval k for each parameter value. The benefits of the LHS
method is that it ensures uniform coverage across the parameter space. Unlike true random
sampling, a set of parameter combinations can be generated such that the entire parameter
space is covered. True random sampling could by chance miss regions of the parameter space.
This method was implemented in the simclone framework by creating a matrix of k number
of samples by 12 parameters with values (’lhsi ’) normally distributed between 0 and 1. The
pyDOE (https://pythonhosted.org/pyDOE/) implementation of the LHS algorithm was used to
generate the matrix using the “maximin” option. This option maximizes the minimum distance
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between any two sampled points. This option was chosen to increase the coverage and evenness
of the parameter space. The matrix was transformed by linearly scaling the LHS generated
values by the parameter ranges shown in equation 2.1.

xi = lhsi ( xmax − xmin ) + xmin

(2.1)

For example if a LHS generated value (lhsi ) was 0.4 for a parameter range of xmin = 4,
xmax = 10, the parameter value used in the simulations would be xi = 6.4.
Parameters can also be considered along a logarithmic using the LHS method as well:

pi = 10−lhsi

(2.2)

Parameter values for the logarithmic scaled values are bound by (10−8 , 1). Values below
10−8 were found to be uninformative, in preliminary testing with values below 10−8 , simulations were unsuccesful due to lack of infected individuals to sample. The LHS values for
logarithmic scaled values are bound differently (0, 8) instead of (0, 1).

2.2.4

Clonal expansion in the simclone framework

As discussed previously, clonal expansion is the proliferation of cells, usually triggered as a
response to an antigen. As the name suggests, daughter cells from these divisions tend to be
clonal. There are some mutations introduced during cell division, however cellular proliferation has a negligible rate of mutation when mutations introduced by HIV-1 Reverse Transcriptase. In the simclone framework we assume that clonal expansion does not introduce any
mutations. Clonal expansion is a parameter that can be controlled in the simclone framework
(ll br). In the simclone framework, it is coded as an transmission event between two latentinfected cells.
A phylogenetic tree is a graph structure that represents the evolutionary relationships be-
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tween sequences or individuals. Fig. 2.2 is an example of a rooted tree. In this structured graph,
the nodes at the end of a tree (also called leaves) represent the observed sequences. These are
labeled A, B, C, D and E in Fig. 2.2. In a rooted tree, all the tips are eventually joined until the
branches collapse to a singular node called the root (R). In between the tips and the root nodes,
there are internal nodes and edges. Internal nodes can represent sampled or unsampled individuals. The structure of the internal nodes and edges (i.e. how nodes and edges are arranged) can
vary as it is dependent upon the relationships between the tips and preceding internal nodes.
The length of the edge between two nodes can represent the genetic similarity between the two
nodes; this is a weighted edge in graph theory. Two nodes connected by a shorter arc are more
genetically similar than two nodes connected by a longer arc. Arcs are drawn proportional to
their weight. In the tree depicted in Fig. 2.2, A and D are the same distance from the root (R),
thus these two samples are equally divergent from the root sequence. It is important to note
that the A and D are not necessarily identical, rather they differ from the root (R) in the same
magnitude. For example if the root had the sequence “AAAA”, tip A could have the sequence
“AAGG” whereas tip D could have the sequence “AATT”. Tip E is closer to the root than any
other sequence, and is therefore the least different from the root. Two identical nodes will be
connected by an edge with a length of zero. These are also known as polytomies.
Weighted edges representing evolutionary distance can be exploited to approximate the
“store and retrieve” hypothesis in the simclone framework. Under the “store and retrieve” hypothesis of latent reservoir maintenance, ancestral HIV sequences are “stored” through latency
then reactivated months, or possibly years later (Lythgoe and Fraser, 2012). To capture clonal
expansion in this framework, evolution needs to be halted as soon as sequences enter the latent
reservoir. Since twt provides transmission history, edge lengths can be replaced with zero as
soon as the viral lineage is recognized in a latent type cell (through transmission or transition).
As edge lengths represent evolutionary distance, setting edge lengths with 0 when sequences
enter the latent reservoir in effect halts evolution. The following tree pruning algorithm (Alg.
1) was implemented in R. It recursively considers all pairs of nodes in the tree in order from
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Figure 2.2: Simple Phylogenetic Tree. R represents the root node of the tree. Tips are labeled
A - E, and represent observed sequences. In a phylogenetic tree, horizontal distance represents
genetic similarity (distance) between two points. Internal nodes (non labelled nodes) represent
unobserved, inferred ancestors between the tips and the root.
the root node to Ni ; where as i is the total number of nodes in the tree. If the node represents
an active type cell, the edge is tagged as ‘Active’. Otherwise, if the parent node is a latent type
cell, the length of the edge is set to 0, and the edge is tagged as ‘Latent’.
Algorithm 1 Tree Branch Shortening Pseudo-code
while Remaining Nodes do
if Parent Node is Active then
Edge T ype ← Active
else if Parent Node is Latent then
EdgeLength ← 0
Edge T ype ← Latent
Next Node
The effect of shortening branches in the phylogenetic tree is scaled back evolution over
parts of the original phylogenetic tree. As an example, consider the tree in Fig. 2.2. Sequence
B and sequence C enter the latent reservoir at the parent node of the two sequences. Fig. 2.3
shows the tree that results from the branch shortening process. Sequence B and C are now a
polytomy. These scaled trees are now ready for simulating nucleotide evolution.
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Figure 2.3: Pruned phylogenetic tree created by modifying tree found in Fig. 2.2. There is no
horizontal distance between tips B and C. These two sequences are a polytomy; and would be
interpreted as a clonal expansion event in the simclone framework.

Parameter Types
Transmission Rates

Parameter Description
Active - Active Transmission Rate
Active - Latent Transmission Rate
Clonal Expansion Rate
Transition Rates
Active - Latent Transition (Latency)
Latent - Active Transition (Reactivation)
Death Rates
Active Death Rate
Latent Death Rate
Replenishment Rates
Active Replenishment Rate
Latent Replenishment Rate
Initial Compartment Size Active Compartment Size
Latent Compartment Size
Replenishment Compartment Size

Parameter Name
AA br
AL br
LL br
AL tr
LA tr
A dr
L dr
RA tr
RL tr
Active size
Latent size
Replenish size

Label
1
2
3
4
5
6
7
8
9
10
11
12

Table 2.1: simclone parameters. Parameter suffixes denote type of event or cell type parameter.
Prefixes denote involved compartments. First letter is source/origin, second letter (if applicable) is recipient. Label column refers to label in 2.1
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INDELible

The software INDELible (W. Fletcher and Yang, 2009) is used for simulating nucleotide evolution. INDELible is a software that can simulate insertions, deletions, and substitutions over
a variety of evolutionary models. A key feature of INDELible is that it allows for heterogeneity of substitution rates among sites, as well as along different parts of the phylogenetic tree.
INDELible utilizes a Markov Chain process to simulate evolution along the entirety of the sequence. Null-order Markov Chain are processes whereby the probability of an event occurring
is only related to the current state of a system (i.e. it is independent of states preceding the current state) (Gagniuc, 2017). To illustrate the Markov Chain process, consider the game Snakes
and Ladders. It is a game where each player takes turns rolling die in sequence. The number rolled on the die is the number of spaces an individual can move forward on a numbered
grid. The outcome (i.e. the new position of an individual) of each die roll is only dependent on
the state of the player when the die are rolled. Gillespie’s algorithm is used to implement the
simulation process. In brief: there is a probability distribution for substitution (S), deletions
(D), and insertion events (I); where as the total rates for all event types is lambda (λ) (λ= S
+ D + I). Depending on the model of evolution selected, the substitution rate can vary per
site. At a given time point si , sampled from an exponential distribution (s ∼ λ exp(−λt)), the
type of event is randomly selected based on the model of evolution. If the chosen event is a
substitution event, the site of evolution is randomly selected, but the evolution model defines
the probability of the substitution type. The next sampling time for a branch is given derived
through λ. Further discussion can be found in the publication. INDELible simulations are
managed through control files. There are three items of note in the control files generated for
INDELible: the evolution model; the phylogenetic tree; and the template for the evolution. In
the simclone framework, the simplest model of nucleotide simulation is the default. The Jukes
Cantor model of nucleotide substitution (JC69) assumes equal base swapping frequencies, as
well as equal base frequencies. Other models of nucleotide evolution can be chosen as well.
Thus, any model that INDELible supports can be implemented within the simclone framework.
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A Python script I wrote inserts the modified phylogenetic trees (with pruned branches) from
the twt simulation step into the control file templates. This Python script has command line options that grants flexibility when creating INDELible control files. The phylogenetic trees are
in the Newick format. A representative HIV-1 env sequence retrieved from NCBI (Reference
Sequence: NC 001802.1) was used as a the template sequence for evolution. NC 001802.1 is a
9181 basepair ssRNA (single strand RNA). The env gene was chosen as a candidate simulation
gene because of its widespread study in literature. This gene is under strong selective pressure
due to its role in immune evasion, consequently there is high variability in this sequence (Aloia
et al., 1993; Zanetti et al., 2006; Zhu et al., 2006). Finally, a seed is included in the control
file to ensure the experiment can be replicated, seeds are randomly generated so they differ
between replicates. A sample control file is attached in the supplementary section. The input
and output genetic sequence for INDELible are in the FASTA format. The FASTA format is
a text-based format for storing nucleotide or amino acid sequences. In the FASTA format,
sequence headers contain information about the following sequence. Headers are denoted by
the ‘>’ symbol. The line that immediately follows the header sequence contains the sequence.
Each letter in the sequence line represents a nucleotide (A, C, G, or T) or amino acid (A, R, N,
...).

2.3

Parallel Computing

Relatively long simulation times due to high replicate and sample numbers necessitated the
implementation of parallel computing. The longest and most computationally intensive step
is typically the twt simulation stage. While each twt simulation was not computationally expensive, the high number of replicates per experiment resulted in a high total cost. Since each
twt simulation were independent from each other, simulations could be run in parallel. Parallel computing was implemented through the mpi4py library in Python (https://github.com/
mpi4py/mpi4py). Parallel computing is not strictly necessary to run this pipeline. However,
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it can greatly increase the overall speed of a set of simulations by removing the need for each
simulation to wait for the completion of the previous simulation. Due to the low compute cost
of the nucleotide evolution simulation step, only the population dynamics simulation step was
refactored for parallel computing. It is possible to run the nucleotide evolution step on cluster
computing, however.

MPI and Parallel Computing
Message Passing Interface (MPI) is a protocol for passing commands between distributed computing resources. It is a structured protocol that allows processes to be aware of the status of
other ongoing processes. The mpi4py library provides methods for making use of MPI classes
such as communicators. To enable MPI methods in a Python script, the mpi4py module in
Python and the MPI module on the cluster must be enabled – this is specific to the RHEL distributions of Linux. Generally, there are two ways of using MPI for parallel computing. First
is to distribute tasks equally over the available nodes and processing threads on initialization.
This is the simplest method to implement, and does not require an active listener to assign new
tasks to idle processes. For each process, a queue is initialized with an equal number of tasks to
run. If these tasks do not require the same amount of time, or there is excessive variation in the
time to complete different tasks, this method of task distribution can result in idle nodes. twt
simulations do not necessarily take the same amount of time to complete. There are scenarios
where the simulation will stochastically fail on the extreme ends of parameter combinations.
For example, at the extreme end of parameter settings the number of infected cells can fall
below the number of cells needed to be sampled, therefore resulting in a failed simulation. twt
will re-attempt the simulation n times (default n= 3) before marking a simulation as unfeasible.
The task distribution method can be modified for this behaviour. On initialization, a listening
process is created with a task queue. Upon receiving a ‘completed’ signal from the worker
thread, the listening process assigns the next task in the queue to the idle worker thread. This
continues until all the tasks are completed.
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2.4

Performance

There were two computing resources used in the performing simulation and analysis. The
“workstation” is a custom built desktop computer used for bioinformatics work. Most work
preformed on the workstation was conducted through (secure shell) ssh/command-line access
due to the restrictions imposed by the COVID-19 pandemic. The computing cluster “BEVi –
Bio-informatics and Evolution of Viruses” is a shared computing resource used among members of the lab group. BEVi in the Western University Data Centre, and was also accessed
through ssh/command-line. Technical specifications for the computing resources can be found
in Table 2.2. Performance estimates were based on default settings of the simulation pipeline:
1000 samples taken from some parameter distribution, with 10 replicates per sample.

Computing Resource
Specifications
Name
Node Name
CPU
Cores RAM
OS
Workstation (Langley)
N/A
Intel Xeon E5-1650v4
6
16 GB Ubuntu 18.04.5
Computing Cluster (BEVi)
Head Node
2 x Intel Xeon E5-2667v4
16
64 GB
CentOS 7.9
Compute Node 0 2 x Intel Xeon E5-2667v4
28
56 GB
Compute Node 1 2 x Intel Xeon E5-2667v4
28
112 GB
Compute Node 2 2 x Intel Xeon E5-2667v4
28
112 GB
Compute Node 3 2 x Intel Xeon Gold 6248
40
192 GB

Table 2.2: Technical specifications of computing resources

The three distinct sections of the simulation pipeline are: parameter combination generation; population dynamics simulation and tree generation (twt); and nucleotide evolution simulation. On BEVi, the computation time estimate for a simulation experiment of 1000 samples,
of 10 replicates each was approximately 2 days. On the workstation, the same simulation experiment would take over 7 days. The parameter and control file generation, and nucleotide
evolution simulation stages were relatively quick (2 minutes, and 30 minutes respectively)thus implementing these two stages into the cluster computing pipeline was not done. In addition, the parameter and control file generation stage is not a good fit for cluster computing, as
LHS generation and control file generation is not easily broken down into smaller tasks.

2.5. Simulation outputs
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Simulation outputs

Simulations are an important tool for understanding processes that are not easily measured in
vivo for practical or for financial reasons. Simulations can reveal underlying mechanisms behind processes that can then be applied to real-world analyses. For example, simclone pipeline
captures cell level transmission and transition, data that could never be captured when studying
the latent reservoir in vivo. The parameters can also be tweaked to study hypotheses that would
be unpractical or unethical in vivo. Samples of the outputs mentioned in this section can be
found in supplementary materials.

2.5.1

Parameter Combination Generation

The output of the parameter combination generation is a directory that contains all the necessary files and sub-directories for the entire pipeline. Two key outputs are the comma-separated
values file (csv) that contains all parameter combinations, and the control files for the next
step: population dynamics simulation and tree generation. In this stage the Latin Hypercube
Sampling method from the pyDOE Python library is used to generated a 12 by n matrix. This
matrix is scaled to the parameter distributions defined by the user. The naming scheme for each
sample/replicate is “{n} {sample/rep}”. The parameters for each replicate is stored as a CSV for
further downstream analyses.

2.5.2

Population dynamics simulation and tree generation

As discussed, the first step of the twt simulation stage is modelling the growth of the infection in
the cell types. The output of the population dynamics simulation is an R6 object that contains
all transmission and transition events that occurred during the simulation. Fig. 2.4 shows a
single representative outcome of a stochastic population dynamics simulation process. It is
a non deterministic process (i.e. there is a different outcome for the same parameter values).
This graph shows the changes in population sizes for a representative simulation. The index

36

Chapter 2. Simulation Model (Simclone)

case always starts in an active cell. Depending on the parameter combinations being tested,
this population dynamic graph will appear differently. Blue lines in this figure represent the
susceptible population for a cell type. Red lines represent the infected population. The graph is
plotted on reverse simulation time axis, where the x-axis starts at the maximum simulation time
(10 in Fig. 2.4) and ends at zero. This is the effect of cells moving from the replenishment cell
type. As time passes, the number of infected active type cells rapidly increases exponentially.
Latent type cells are infected much slower, but still at a steady rate (9.92 × 10−6 transition
events / Unit Time). ART initialization happens at t = 5. At this point, infection between active
type cells no longer occurs, the infected active type population starts to decrease. In addition,
the number of susceptible active type cells start to slowly reappear. Outputs of the population
dynamics simulation are saved to various folders in the experiment directory. The transmission
and transition events are extracted and saved as a CSV file. A line plot displaying the trajectory
of population changes (e.g. Fig. 2.4) is saved for visual inspection. In addition the outer plot
showing the transmission tree for sampled individuals is saved for the same reason.

Figure 2.4: Line graph showing changes in susceptible (labelled with ”S” prefix) and infected
(labelled with ”I” prefix) populations in all cell types during initial population dynamics simulation.

As discussed previously, the transmission ‘outer’ tree is used to simulate the phylogenetic
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shortening
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(b) Sample phylogenetic tree in (a) with
branches shortened when lineages enter latent
type cells

Figure 2.5: Phylogenetic trees generated by twt simulation. Branches are coloured based on
the cell type. Branches that are red are when viral lineages are in active type cell. Branches
that are blue are when viral lineages are in latent type cell
‘inner’ tree. The are modified using the branch shortening method described previously. The
phylogenetic tree is then saved as a Newick file for the nucleotide evolution simulation. A
coloured version of the phylogenetic tree is saved as well (see Fig. 2.5b). In addition, the
Newick file is modified to remove artifacts that INDELible cannot process. The tree structure
does not change, only the interior node names are removed.

2.5.3

INDELible

The modified phylogenetic trees generated by the previous stage are inserted into a control file
template for INDELible. See supplementary section for an example INDELible input. The rest
of the control file is constructed as per the specified nucleotide evolution model. These control
files are saved to tree specific directories. INDELible is then directed to these directories on
a replicate-by-replicate basis. INDELible outputs two FASTA files that contain a number of
evolved HIV env sequences. The number of sequences in the INDELible output FASTA file
depends on the number of samples specified within the twt simulation. This number is the
number of cells that are sampled from the active and latent cell types respectively.

Chapter 3
Summary statistics
3.1
3.1.1

Background
Measures of Clonality

Replication of the HIV genome is highly error prone, due to the lack of a proof reading mechanism in RT (Boeras et al., 2011; Cavarelli and Scarlatti, 2009; Hu and Hughes, 2012; Telesnitsky, 2010). As such, the presence of identical integrated HIV-1 DNA sequences, is taken as an
indication that clonal expansion is the underlying cause of HIV persistence in the latent reservoir (Chavez et al., 2015; Crooks et al., 2015; Siliciano et al., 2003; Yeh et al., 2021). However,
it is difficult to quantify the size and diversity of the latent reservoir, reasons include: relative
abundance of the latent reservoir is low; assays are insensitive; and different quantification
techniques systematically over or underestimate the diversity and size of the latent reservoir
(Ferreira et al., 2021; Massanella and Richman, 2016).
Clonality is a measure of the occurrence of identical genetic sequences in a population
(Ferreira et al., 2021; Hosmane et al., 2017; Joos et al., 2008). Clonality of the latent reservoir is used to infer the mechanism of latent reservoir maintenance. Higher levels of clonality
are taken as evidence that clonal proliferation is the method for latent reservoir maintenance.
(Hosmane et al., 2017). Tracking the genetic drift of a population, and the speed at which
38
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mutations become fixed in the latent reservoir can address conflicting establishment and maintenance hypotheses. The latent reservoir has been shown to become increasingly clonal over
time, suggesting cellular proliferation to be the mechanism of maintenance (Cohn et al., 2015).
In the “store and retrieve” hypothesis, HIV-1 variants seed the latent reservoir early in the infection, and is maintained through cellular proliferation. In support of the “store and retrieve”
hypothesis, it has been reported that the vast majority of integration events occurs near the start
of ART (Chavez et al., 2015, Abrahams et al., 2019; Brodin et al., 2016). Another possibility
is that the latent reservoir could be seeded continuously during active infection (B. R. Jones
et al., 2018). The latent reservoir could also be maintained through low level HIV activity
in drug sanctuaries or environments otherwise permissive of viral replication. HIV activity in
these sites results in ongoing infection and then latency of the reservoir (C. V. Fletcher et al.,
2014). However it should be noted that apparent clonality can occur for reasons other than
clonal proliferation. For example, ineffective ART can provide a strong selective force for a
particular set of drug-resistant mutations. A ‘hard sweep’ event can occur, limiting the genetic
diversity. Hard sweeps are selection events that result in fixation of mutations in a population
(e.g. selection of antibiotic drug resistance genes in a population of bacteria after exposure
to antibiotics). After this sweep, the population would appear to be less heterogeneous, even
without clonal expansion (Feder et al., 2016).
There are clonality metrics that report clonality by quantifying the genetic diversity of the
latent reservoir from observed quantities of genetic variation in the sequences.

3.1.2

Proportional Clonality

A proportional clonality score is the most frequently used method of calculating identicality
in latent reservoir research (Wagner et al., 2014, von Stockenstrom et al., 2015). It can be
calculated as the proportion of sequences that are identical to one other sequence in a sample
(Eq. 3.1). In Figure 3.1., there are 5 individuals that share at least one identical sequence: a
clonality score of 5/6 = 0.83 (von Stockenstrom et al., 2015; Wagner et al., 2014).
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Figure 3.1: Circles that share the same border pattern are identical. Edges that connect two
identical circles are dashed. Solid edges are non-identical comparisons.

The proportional clonality metric has limitations. In particular, proportional clonality statistics are biased as a result of incomplete sampling (Reeves et al., 2017), resulting in systematic
underestimates of the size of the latent reservoir. This is because latent reservoir has a skewed
distribution, where a small number of unique variants constitute a large proportion of the individuals in the reservoir (Hoehn et al., 2015). Therefore, there is an equal probability of
sampling an unique sequence as sampling proportion increases. In particular, as sampling proportion increases, more is revealed about the genetic structure. Lower sampling proportion
However, with the proportional clonality score, information about the underlying structure,
such as number and size of polytomies are lost. Notably, in the proportional clonality metric,
information about sequences are collapsed into a binary “singleton” vs. “not-singleton” count
(Ferreira et al., 2021).

Proportional Clonality =

Σi ni I(ni > 1)
Σi ni

(3.1)
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Gini coefficient

There are clear limitations to the proportional clonality scores. Therefore a score that takes
into account the genetic diversity and structure of a sample is necessary. The Gini coefficient
(G) is a method for measuring the distribution of some resource over of groups (Gini, 1936).
It is typically used in economics, to estimate the distribution of wealth over the population. It
has also been used in ecology and immunology research to measure the distribution of genetic
variability over some distribution of individuals (Thapa et al., 2015, Sadras and Bongiovanni,
2004). The Gini co-efficient has been use to varied effects by (Bashford-Rogers et al., 2013;
Hoehn et al., 2015) to estimate within host HIV genomic diversity. The Gini co-efficient ranges
from 0 to 1 where populations with Gini coefficients closer to 0 have the most homogeneous
distribution (most evenly dispersed genetic variation among individuals); populations with values closer to 1 have the most skewed distribution. G is calculated by taking the proportion of
the space between the two curves in Fig. 3.2 (

i
(i+ii)

). In 3.2, the area under the dotted line (i

+ ii) represents perfect equality - where each sequence contributes an equal amount of genetic
diversity in a population. The solid line curve separating areas i and ii is the Lorenz curve. The
Lorenz curve describes inequality of genetic diversity in a population. For calculating genetic
variablity, the cumulative share of individuals is plotted on the x axis, and the cumliative share
of diversity is plotted on the y axis. Unlike the proportional clonality score, G is able to differentiate between a completely identical population, and a population that has two groups of
identical sequences. For example, G for a population with the distribution [1,2,3] (G = 0.222)
is lower than G for a population with the distribution [1,5] (G = 0.333). For both of these
populations, the proportional clonality score would have been 0.833.
An approximation for the G can be found in Eq. 3.2 for population with n groups of y individuals, with values yi to yn , that are indexed in monotonically increasing order (yi ≤ yi+1 ). This
formula approximates the area of ii) in Fig. 3.2 instead of fitting a curve. G does not behave
optimally as the number of unique sequences decreases, especially as it approaches 1. This is a
result of the G approximation for discrete values. For a population that is completely identical,
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Figure 3.2: Graphical representation of the Gini co-efficient calculation. The Gini co-efficient
is calculated by dividing area i by areas i + ii. For the approximation of the Gini co-efficient, ii
is approximated by step wise discrete values.

G = 0. In general, as the number of unique sequences decreases the Gini coefficient starts to
fluctuate wildly. G is dependent on the number of groups in the sample. For example consider
two populations; one with the distribution [0,100] (G = 0.500); and the other [0,0,0,100] (G =
0.750). There is higher in-equality in the second population because there are a greater number
of groups with 0, as compared to the one group with 100. This property of G is one reason that
may not be ideal for calculating genetic diversity for a population that can be highly clonal. It
is impossible for there to be a group with ‘0’ members when using the G to measure sequence
diversity.

1
G = (n + 1 − 2
n

Pn

+ 1 − i)yi
Pn
)
i=1 yi

i=1 (n

(3.2)
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Pairwise Clonality

Due to the drawbacks of proportional clonality and the Gini coefficient, I propose the pairwise
clonality measure. The pairwise clonality calculation is shown in Eq. 3.3.

Pn P
j>i I(i, j)
i=1
n
Pairwise =

(3.3)

2

where I(i,j) = 1 if sequence i == sequence j, otherwise 0
Plainly, the pairwise clonality statistic is the proportion of pairwise comparisons between
sequences that are identical. It addresses some of the shortcomings identified with the previous
clonality scores. The pairwise clonality score is a linear score. Unlike the Gini co-efficient,
as a population becomes more homogeneous, the pairwise clonality score increases in value.
The inverse is true - as a population becomes more heterogeneous, the pairwise clonality score
decreases in value. The rationale behind this measure is that identity is not a attribute of a single
individual. The comparison between two observations can be identical. A single observation
cannot be identical in-itself. In addition, the pairwise clonality statistic has nice statistical
characteristic. Each identity comparison - that is each comparison between two individuals –
is an independent event from other comparisons. This provides a more reasonable statistical
framework for evaluating clonality results.

3.2
3.2.1

Methods
Calculating Clonality

The FASTA files from the INDELible simulation stage were processed to calculate each aforementioned clonality metric (proportional clonality, Gini coefficient and pairwise clonality). For
each FASTA file, the number of each unique sequence was counted. To automate sequence processing, FASTA files were processed in Python. Hashing is a deterministic algorithmic method
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that transforms data into a set length value. The Python implementation of the hash function
(https://docs.python.org/3/library/ hashlib.html) transforms any input into a fixed length integer. The hash function implemented in Python ensures there is low chance of collision (two
objects generating the same hash). Thus, hashing is a vastly superior alternative than an exhaustive linear comparison of two sequences. Each simulated sequence was hashed once, and a
dictionary was created with the name of the first sequence processed for each unique sequence;
the hashed value keyed by the unique sequence; and a count of how many times the hash was
observed. The dictionary was used to calculate the proportional clonality score (Eq. 3.1) and
the Gini co-efficient (Eq. 3.2). For the pairwise clonality score, a recursive function was written that considered every comparison possible between all sequences. For a population with n

individuals, there are n2 possible unique comparisons. After the pairwise comparison between
individuals i0 and i1 has been considered, the comparison between individuals i1 and i0 does
not need to be considered. The recursive function I wrote in Python considers all comparisons
for an individual i x indexed on x (where 0 < x < n), then moves on to consider i x+1 , removing
individual i x from consideration. The function recursively considers all individuals until none
are left. As shown in Eq. 3.3, the pairwise clonality score is the proportion of all pairwise
comparisons that are identical.

3.2.2

Regression Analysis

At its core, the purpose of linear regression is to predict a value y on the basis of another value
x. The variable x is the ‘predictor’ or ‘independent’ variable whereas the variable y is the
‘outcome’ or ‘dependent’ variable. Linear regressions can rely on one or more independent
variables to predict the value of the dependent variable. A linear regression is fit to the data by
estimating coefficients of the independent variable(s). Regression coefficients are estimates of
parameters, they quantify the relationship between the independent variable and the response
variable. These regressions can be compared to determine what coefficients result in the best
fit for the data. Eq. 3.4 shows the general formula for a multi-variable linear regression. To
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estimate “y”, the coefficient “b” is calculated for n independent variables (x) (“Simple linear
regression”, 2005).

y = b0 + Σi bi xi

(3.4)

Generalized Linear Models (GLM) are an expansion of linear regression. A key component
of the GLM is the ’link function’ that allows response variables to vary in a non-linear fashion
(Nelder and Wedderburn, 1972). Another component of the GLM is allowing the distribution
of response variable to vary (i.e. binary response to a linear regression (0,1)). For example
using simple linear regression to predict a binary categorical response (i.e. clonal vs. singleton)
would return nonsensical results, as linear regression makes the assumption that y is a linear
function of x. Instead a binomial distribution link function can be used in a GLM. A variety of
link functions can be used in a GLM; Poison, Binomial, Bernoulli to name a few.

3.3
3.3.1

Results
Analyzing Clonality Scores

A benefit of simulations is the ability to control the input parameters. Unlike real-life experiments, simulations can be tuned to test specific hypotheses. As discussed previously, transmission and transition rates can be controlled in the simclone framework. Identifying the strength
of relationship between transmission/transition rates and clonality scores is possible through
GLM analyses. Identifiability of parameter values from clonality scores (e.g. estimating the
levels of clonal expansion from the clonality score alone) can provide validation for analyses
that use clonality scores to infer the method of latent reservoir persistence.
Identifiability of parameter values using clonality metrics (proportional, Gini co-efficient,
pairwise coefficient) was tested by fitting GLM on simulation results. Increasing clonal ex-
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pansion the rate of clonal expansion should be correlated with increased number of identical
sequences (clones). Analysis of simulated sequences reveal that this is not the case for all
clonality measures.
A GLM was fit with the three clonality scores as the response variable with all simulation
parameter values as independent variables. The link function used to fit the GLM was the binomial family. Proportional Clonality was not significantly associated with increased clonal
expansion when all parameters were varied (p = 0.324) nor when only a subset of parameters
were varied [Active to Active infection rate, Active to Latent infection rate, Clonal Expansion]
(p = 0.846). The Gini coefficient was significantly associated with increased clonal expansion
when all parameters were varied (p = 1.0×10−4 ), but not when only the same subset of parameters as above were varied (p = 0.242). The pairwise clonality score was significantly associated
with increased clonal expansion when all parameters were varied (p < 2e-16) and also when
only the same subset of the parameters were varied (p < 2e-16). Parameters that introduce or
propagate viral lineages to the latent reservoir were chosen for the subset. The subset was used
to reduce simulation noise to test associations. Other associations were tested using the GLM
method as well.
Figures 3.3, 3.4, and 3.5 show the three clonality scores (proportional, Gini and pairwise)
calculated for the same simulation run. All simulation parameters were varied. The number of
simulated sequences for each replicate is 100. Thus the possible range of clonality scores are:
proportional clonality (0 - 100); Gini co-efficient (0 - 1); and pairwise clonality (0 - 1). The
Gini co-efficient was significantly associated with Active to Active infection rate (p = 0.006),
and Latent to Latent infection rate (p = 0.0001) when all parameter values were varied. When
only a subset of simulation parameters were varied, only the Active to Active infection rate
was significant at the α = 0.05 level (p = 0.007).
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Figure 3.3: Proportional clonality score drifts upwards as clonal expansion rate was increased.
Clonal expansion parameter is on the x-axis, log-normal scaled between 0 and 1. X values
represent clonal expansion events per simulation unit time. Y-axis is proportional clonality
score, possible values range between 0 and 100. Each point represents one simulation replicate.
All simulation parameter values were varied for this simulation run. Proportional clonality was
not significantly associated with clonal expansion p = 0.324.

Figure 3.4: Gini coefficient is inversely correlated with clonal expansion. Clonal expansion
parameter is on the x-axis, log-normal scaled between 0 and 1. Y-axis is Gini coefficient score,
possible values range between 0 and 1. All simulation parameter values were varied for this
simulation run. Gini coefficient was significantly associated with clonal expansion when all
parameter values were varied p = 0.0001.
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Figure 3.5: Pairwise clonality is correlated with clonal expansion. Clonal expansion parameter
is on the x-axis, log-normal scaled between 0 and 1. Y-axis is pairwise clonality score, possible values range between 0 and 4950. All simulation parameter values were varied for this
simulation run. Pairwise clonality was significantly associated with clonal expansion when all
parameter values were varied p ¡ 2e-16

Simulation Parameter
(Intercept)
Initial Active-type Population
Initial Latent-type Population
Initial Replenishment Population
Active-to-Active Transmission
Active-to-Latent Transmission
Clonal Expansion
Active-to-Latent Transition
Latent-to-Active Transition
Active Death Rate
Latent Death Rate
Active Replenishment
Latent Replenishment

Adjusted Odds Ratio (95% CI)
Proportional
Gini Coefficient
Pairwise Clonality
Clonality
1.53e+01 ( 9.72e-02, 3.23+03 )
1.95 ( 2.88e-01, 1.34e+01 )
1.19e+01 ( 1.15e+01, 1.23e+01 )
1.0 ( 1.0, 1.0 )
1.0 ( 1.0, 1.0 )
1.0 ( 1.0, 1.0 )
1.0 ( 1.0, 1.0 )
1.0 ( 1.0, 1.0 )
1.0 ( 1.0, 1.0 )
1.0 ( 1.0, 1.0 )
1.0 ( 1.0, 1.0 )
1.0 ( 1.0, 1.0 )
Inf. ( 0, Inf. )
0 ( 0, 0 )
Inf. ( Inf., Inf. )
0 ( 0, Inf. )
Inf. ( 0, Inf. )
0 ( 0, 0 )
61.42 ( 4.39e-01, 1.543e+08 )
9.62e-02 ( 2.72e-02, 3.08e-01 )
134.20 ( 127.36, 141.08)
1.91e-01 ( 0 , Inf. )
1.44e+221 ( 4.36e-113, Inf. )
0 ( 0, 0 )
Inf. ( 0, Inf. )
Inf. ( 0, Inf. )
0 ( 0, 0 )
3.256e+05 ( 2.59e-85, 1.71e+94 ) 1.60e-21 ( 1.61e-54, 8.89e+11 ) 1.68e+19 ( 4.71e+18, 6.01e+19 )
3.12e+11 ( 4.58e-79, 1.09e+102 ) 1.21e-06 ( 6.32e-40, 1.96e+27 )
0 ( 0, 0 )
Inf. ( 0, Inf. )
Inf. ( 0, Inf. )
0 ( 0, 0 )
0 ( 0, 0 )
0 ( 0, 0 )
0 ( 0, 0 )

Table 3.1: No parameters were significantly associated with clonality across all three clonality
measures. Bolded adjusted Odds Ratios indicate point estimates with 95% CI intervals that do
not overlap OR = 1. Adjusted odds ratios were calculated with GLM (binomial link function)
fitted to simulation data with all parameters varying with clonality measures as the response
variable.

3.3. Results
Adjusted Odds Ratio (95% CI)
Proportional
Simulation Parameter
Gini Coefficient
Clonality
(Intercept)
2.08e+02 ( 1.02e+01, 1.10e+04 ) 4.75-01 ( 3.01e-01, 7.90e-01 )
Active-to-Active Transmission
7.48+03 ( 7.54e-02, NA )
2.21e-1 ( 6.85-02, 6.25e-01 )
Active-to-Latent Transmission
0 ( 0, Inf. )
Inf. ( 1.57e-87, Inf. )
Clonal Expansion
Inf. ( 0, Inf. )
0 ( 0, 7.13e+154 )
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Pairwise Clonality
3.89 ( 3.85, 3.92 )
1.62 ( 1.60, 1.65 )
0 ( 0, 0 )
Inf. ( Inf., Inf.)

Table 3.2: When only a subset of parameters were varied, none of the parameters avoided
overlapping AOR = 1 for all three clonality measures. Bolded adjusted Odds Ratios indicate
point estimates with 95% CI intervals that do not overlap OR = 1. Adjusted odds ratios were
calculated with GLM (binomial link function).

Adjusted odds ratios (AOR) were calculated for each simulation parameter value that was
varied for both of the above GLMs. Adjusting the odds ratios was necessary to adjust for
confounding variables. AOR 95% Confidence Intervals (95% CI) that do not span AOR = 1
indicate significant predictor variables. When all parameters were varied, no simulation parameter was significant for all three clonality measures ( Table 3.1). No parameter Confidence
Interval spanned the AOR = 1 for the proportional clonality score. For G, only the clonal expansion parameter was significant. The clonal expansion parameter was negatively associated
with the Gini coefficient. For the pairwise clonality score, both the clonal expansion parameter
and the Active Death Rate parameters were significantly associated with increases in pairwise
clonality.
The GLM analyses show clonality scores that take into account the population structure
(i.e. Gini coefficient and pairwise clonality) perform better at predicting changes in clonal expansion than clonality scores that do not (proportional clonality). The discrepancy maybe due
to the inability for the proportional clonality score to take into account the difference between
a completely identical sample and a sample where there are several groups of non-unique sequences. In Fig. 3.1, the proportional clonality score would give a clonality score of 0.83;
the Gini coefficient would give a clonality score of 0.22; and the pairwise clonality score is
0.27. The proportional clonality score, or any other proposed clonality measure that does not
consider the difference between groups of non-unique sequences, would lose vital information about the genetic population structure. The empirical distribution of proportional clonality
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scores is extremely narrow. These clonality values range from 84 to 100, with a mean of 96.5
and an interquartile range of 94 - 99 in Fig. 3.3. Since proportional clonality is an integer
count value, only 5% of possible values contain 50% of the observations. The reduced granularity and inability to differentiate between common clonality scenarios severely limits the
effectiveness of the proportional clonality score.

3.4

Discussion

The Gini coefficient could differentiate between the ambiguous clonality scenario that the proportional clonality score fails to address. Gini coefficient values ranged from 0 to 0.81, with
a mean of 0.57 and a standard deviation of 0.27. The IQR range of Gini coefficient values
was 0.49 to 0.773. As previously demonstrated, the Gini coefficient was able to differentiate
between the scenarios that the proportional clonality score failed to do. The GLM results show
that the Gini coefficient was significantly associated with the clonal expansion parameter. The
main flaw with the Gini coefficient stems from a property of identity: the number of unique
individuals in a population decreases as the population becomes more homogeneous. These
results mirror the findings of (Ferreira et al., 2021; Hoehn et al., 2015), who found noted that
as sampling fraction increased, the number of singletons likewise increased, resulting in higher
Gini coefficients. However, unlike Hoehn et al., 2015, there were significant associations between clonality scores and simulation parameter values - with the caveat that Hoehn et al. were
using attempting to fit clinical variables, not simulation parameters. The simclone parameters
may be more identifiable then clinical variables because of system complexity. It can be reasonably supposed that the simclone framework has less complexity, and opportunity for variability
than real-world data due to simplifying assumptions. The number of unique sequences has a
disproportionate effect on the G, especially as the number of unique individuals approaches 1.
For example consider the following 3 populations: population a with the distribution [98,1,1;
G = 0.647]; population b with the distribution [99,1; G = 0.490]; and population c with the
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distribution [79,16,5; G = 0.491]. The Gini coefficient would suggest that population a is more
unequal than populations b and c; and population b and c are approximately unequal to the
same extent. The Gini coefficient loses specificity as the number of unique sequences drops.
The Gini coefficient is a measure of inequality across unique groups, as the number of unique
groups decreases, the level of inequality decreases for remaining groups. In this way, it falls
into a similar trap as the proportional clonality score. There exists multiple population distributions with very different population structures that can be represented by the same Gini
coefficient. Beyond the collision of Gini coefficients for distinct distributions, as the number
of unique sequences decreases, the Gini score does not decrease in a linear fashion. The Gini
coefficient for a completely clonal population is 0; whereas as the population approaches complete clonality, the Gini coefficient increases. The population is becomes more unequal as the
membership to unique sequence groups increases. These two issues significantly limit the usefulness of the Gini coefficient in situations where the a population starts at, or nears complete
clonality.
The pairwise clonality measure considers the genetic structure of a population, while maintaining a stable denominator that does not vary with the homogeneity/heterogeneity of a population. The denominator of the pairwise clonality measure is set by the number of possible

pairwise comparisons between all individuals in a population n2 , where n is the size of the
population. The pairwise clonality measure can capture the changes as homogeneity increases,
and many small unique groups merge into larger unique groups. Considering the same 3 populations as before: population a with the distribution [98,1,1; pairwise = 0.96]; population b
with the distribution [99,1; pairwise = 0.98]; and population c with the distribution [88,15,7];
pairwise = 0.80]. Population a and b have a much more similar population structure, and are
much closer to homogeneity than population c. As shown in this example, the pairwise clonality score is able to capture the not-so-subtle differences in population structures that the Gini
coefficient and the proportional clonality scores cannot differentiate between. The pairwise
clonality score also has a nice statistical property. Identity is not a trait of one object – one
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object cannot be identical. Identity is a trait of the relationship between two objects. As such,
the pairwise clonality score is able to comment on identity in a internally-valid way. It has the
added bonus of ensuring each observation is a quasi independent measure. This provides statistical robustness to following statistical analyses. The pairwise clonality measure also addresses
some of the short comings of the Gini coefficient identified by (Bashford-Rogers et al., 2013;
Ferreira et al., 2021; Hoehn et al., 2015). For the Gini coefficient, as the read depth increases,
the number of clones in the large clones increases, while the number of unique singletons also
increases. The skew of the clonal distribution increases; thus increasing the Gini coefficient
(Hoehn et al., 2015). However with the pairwise clonality statistic, the addition of individuals to large clonal groups, or as singletons does not cause as large variations in the clonality
statistic. These analyses suggest that clonality measures that consider the population structure
would be more robust in capturing changes in the rates of clonal expansion. Whereas the Gini
coefficient may still be a flawed measure, it may still provide usefulness when analysing heterogeneous in populations, as in ecology or immunology research (Sadras and Bongiovanni,
2004; Thapa et al., 2015). There may be situations where the Gini coefficient or the proportional clonality score are a better fit for identifying trends in clonality. Therefore, the goal
of the analysis of the latent reservoir data ( i.e. sequence data ) should be considered when
choosing the best method of analyses.

Chapter 4
Particle Filtering

4.1

Background

General Linear Models are limited, because they require prior knowledge of the type of distribution and relationship between independent and dependent variables to establish associations.
Due to complexity of the simclone model, it is difficult to establish these relationships, therefore I employed the particle filtering method. The particle filtering method is a simulation
based method of fitting a model to observed data using summary statistics. In the domain of
phylogenetics, this particle filtering method has been used to fit complex population dynamic
models to genealogies; and to infer phylodynamic parameters (e.g. reproductive number) from
genetic sequence data without fitting a phylogenetic tree (Park et al., 2021; Rasmussen et al.,
2011). The approach that I took to particle filtering mirrors the approach of the two aforementioned papers. However, calculating likelihood for this complex model is too difficult, as there
are too many parameters to consider. The particle filtering method approximates the posterior
distribution of a model given a noisy observation.
My implementation of the particle filtering method uses a truth simulation run and an experiment dataset simulated using samples drawn from the same distribution that the truth sample
was drawn from (see 4.2 for the experimental design). The clonality scores for the truth sample
53
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is taken as the true clonality values for each of the three clonality scores - [Proportional, Gini,
and pairwise]. These random simulation runs are taken as the ‘truth’, as we don’t have actual
outcome data with the ground truth. The truth samples are used as the target for the particle
filtering method. The experimental dataset consists of x replicates for each sample with each of
the three clonality values calculated for each replicate. Each replicate is considered a particle.
The Root Mean Squared Error (RMSE) is calculated using Eq. 4.1 for each of the particles;
where Exp are experimental clonality scores; and Targ is the target clonality score.

r
RMS E =

1 n  Expi − T arg 2
Σ
n i=1
σi

(4.1)

The resulting RMSE scores can be interpreted as an objective (cost) function, where a
particle with a RMSE score of 0 against a target represents an identical comparison. Lower
RMSE scores represent a clonality score closer to the target simulation. Fig. 4.1 shows the
ideal scenario. In the ideal scenario, the RMSE is a quadratic curve, centered around the true
parameter value. Values that are further away from the target are penalized exponentially.
The exponential penalty should be beneficial to particle filtering. RMSE was also chosen for
proof-of-concept testing since the measure has a for its low computational cost, due to the
high number of comparisons involved. However, the cost function for particle filtering I have
implemented can be changed to a Bayesian framework as in Rasmussen et al., 2011 and Park
et al., 2021.
I treated each replicate in the experimental dataset as a particle. After a RMSE score is
calculated for each particle, the particles are filtered, removing the upper 50% of particles.
In the filtering step, the median RMSE score for all replicates in the experiment dataset is
calculated, and any value above the median RMSE score is removed. The particle filtering
method is outlined in Fig 4.2.

4.2. Method
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Figure 4.1: Visualization of the RMSE particle filtering method. Each (+) represents a particle.
In the ideal scenario, the RMSE values decrease to a minima for particles close to the true
parameter value. The dotted line shows the median RMSE score; particles above the median
are filtered (removed) when estimating parameter scores.

4.2

Method

The target samples and the experiment samples are drawn from the same parameter distribution
using the LHS method discussed in chapter 2. The parameter values are normally distributed
across intervals initially drawn from literature (but adapted to the simclone framework). Target
and experiment samples were sampled using the LHS method to ensure that the chosen targets were representative of the overall parameter space. As described in chapter 2, the LHS
algorithm ensures sampling from the entire parameter range. This is important for the particle
filtering method, because of the possibility that discrete regions of parameter space could be in-
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Figure 4.2: The particle filtering method is an experimental design that sits on top of the
simclone simulation pipeline. The filtered particles are samples in the lower 50% of RMSE
values. Ten target samples were drawn (1 replicate per sample simulated), and 1000 experiment
samples were drawn (10 replicates per sample)
formative; multiple regions of the parameter space could have low RMSE values. Using varied
parameters is important for the target dataset, as portions of the parameter space could conceivably have unique interactions. The experiment simulations were also drawn under varying
model parameter values to calculate a pseudo-likelihood surface based on the RMSE of clonality measures between target and experimental samples. The RMSE surface approximates a
posterior probability, without needing to calculate the likelihood of the models. This surface
was considered for each parameter - i.e. were there regions of parameter space that had lower
RMSE values when considering RMSE against the parameter? The target sample and experiment samples were simulated through the simclone simulation pipeline normally without any
additional modification: i) twt simulation specification files were generated; ii) twt simulations
were conducted on the computing cluster; iii) twt outputs (i.e. lineage tree) were modified to
shorten branch lengths in the latent reservoir; iv) INDELible was used to simulate nucleotide
evolution on twt outputs; and v) clonality scores (proportional clonality, Gini coefficient, pairwise clonality) were calculated using the method discussed in chapter 2. The RMSE values
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were calculated for each of the targets using Eq. 4.1. The filtering step did not necessarily
filter the same particles (replicate) for each target considered, nor for each clonality score.
The RMSE values were appended to the same dataframe with the parameter settings and the
clonality scores.

4.3

Results

There were ten targets considered with this method. These targets were drawn from the same
distribution as the experiment samples using the LHS method. The targets were equally distributed across all parameters. The RMSE values for each particle was calculated using the
described methods above. Each particle had 10 RMSE values for each clonality score: one
for each simulation against a target. Fig. 4.3 shows example histograms for the distribution of
clonality RMSE values for particles against the target.
Histograms show multi-modal distributions for RMSE values across all clonality measures.
However these distributions are highly varied, and are dependent on the target. Histograms are
included to highlight the difficulty of choosing a RMSE threshold. Static thresholds were
difficult to parameterize, as the range and distribution of RMSE values could greatly vary
between targets. The median RMSE value was chosen as the cutoff, to maintain the same
number of particles for each comparison across targets and clonality statistics.
As described previously, particles with an RMSE score above the median RMSE value are
filtered out. Table 4.1 shows the median particle RMSE value for each target, given its target
clonality score. Median value represents the maximum deviation of the filtered particles from
target clonality, as any particle with an RMSE below that value is filtered out. Proportional
clonality trends towards lower median particle RMSE when target proportional clonality score
is high (Fig. 4.4a). Median particle RMSE follows a quadratic trend as target pairwise clonality
and Gini coefficient increase (Fig. 4.4c and 4.4b, respectively).
Proportional clonality is an integer count value that is bounded by 0 - 100 for this ex-
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Target
1
2
3
4
5
6
7
8
9
10
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Proportional Clonality
Gini Coefficient
Pairwise Clonality
Median
Target
Median
Target
Median
Target
Particle RMSE Clonality Particle RMSE Clonality Particle RMSE Clonality
13.12
94
0.901
0.797
2444
4371
4.95
100
1.544
0.000
3334
4950
4.95
100
0.900
0.440
2449
4386
4.95
100
1.900
0.440
4278
2931
15.92
93
0.903
0.798
3182
3756
4.95
100
1.494
0.020
5479
2454
5.66
98
0.754
0.706
4308
2917
10.30
95
0.845
0.768
3716
3229
4.95
100
1.348
0.080
5322
2514
4.95
100
1.398
0.060
7776
1647

Table 4.1: Median RMSE values of particles against their target are presented for targets (n =
10) for proportional clonality, Gini coefficient and pairwise clonality. The same target is used
across the row, but differ between rows. The same particles are considered across all rows.
periment. There are fewer potential outcomes for proportional clonality scores than for Gini
coefficient and pairwise clonality. Proportional clonality collapses many population distributions into a single score (i.e. [(99, 1); (54, 45, 1); and (60, 30, 4, 3, 2, 1)] are all assigned the
proportional clonality score of 99). The reduction in variability, and thus lower RMSE score
may reflect this process. Therefore, comparing RMSE values between targets given a type of
clonality calculation (proportional, Gini, pairwise) is possible, but comparing RMSE values
between clonality measures for a single measure is not. RMSE values for different clonality
statistics cannot be compared because RMSE is a scaled measure; it is dependent on the magnitude of the target and particle clonality values (Expi and T arg). The clonality statistics operate
on different scales (proportional clonality from 0 - 100; Gini coefficient 0 - 1; and pairwise
clonality 0 - 4950), and therefore RMSE values are not comparable. However, comparing particle RMSE scores for various targets can be informative. Given that clonality metrics respond
in some fashion to simulation parameter(s), comparing RMSE values for particles can allow
estimation of the target parameter values from the particles. The median RMSE values does
not necessarily represent how identifiable parameters are, it simply represents the distribution
of the clonality score for the 50% of particles closest to a given target.
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(a) RMSE values for proportional clonality of particle against target 2

(b) RMSE values for Gini coefficient of particle against target 2

(c) RMSE values for pairwise coefficient of particle against target 2

Figure 4.3: Histogram of RMSE values for clonality scores of particles against the same target.
A,B, and C show the same particles measured against the same target. Dashed horizontal line
shows the median RMSE value of all particles. Red are particles with an RMSE value above
the median for this target. Blue are particles with an RMSE value below the median for this
target
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(a) Median RMSE value for all particles by target proportional clonality score, RMSE values calculated
for the proportional clonality score.

(b) Median RMSE value for all particles by target Gini coefficient, RMSE values calculated for the Gini
coefficient.

(c) Median RMSE value for all particles by target pairwise clonality score, RMSE values calculated for
the pairwise clonality score

Figure 4.4: Median RMSE decreases as the target clonality increases for proportional clonality
(a). Median RMSE generally decreases to an inflection point for (a) Gini coefficient and (b)
pairwise clonality. Scatters show Median RMSE score for each target particle, per clonality
statistic (a) Proportional Clonality (b) Gini coefficient (c) Pairwise clonality. Points are the
median RMSE value for a target, plotted against the target’s actual clonality value.
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To test parameter identifiability for a given target, I calculate the mean of the parameter of
interest for only filtered particles. This mean value is the estimate of the true parameter value.
The median RMSE value is calculated for each combination of target and clonality metric, and
a rank value is appended for each RMSE value (1 for below, 0 for above median). For the
filtered particles, the mean of each parameter is taken as the parameter estimate for the filtered
particles. Fig. 4.5 is a visualization for the process. Red points indicate a particle that have
been excluded, blue points indicate particles remaining. The vertical red line on a) and b) is
the actual parameter value. Fig. 4.5 shows the ideal scenario, where the true parameter value
is close to the parameter estimate (mean parameter value of filtered values). Particle filtering
visualizations for all targets are grouped by clonality statistic in the supplementary files.

Figure 4.5: A) RMSE values for all particles plotted against the Clonal Expansion (ll br) parameter. Particle colour indicates whether the particle has been filtered. Blue coloured particles
are the remaining particles, with RMSE values in the lower 50%. B) Distribution of the Clonal
Expansion parameter for the filtered particles in A. The red vertical lines show the target Clonal
Expansion parameter.
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Fig. 4.5 was the exception, rather than the rule for this method. The validity of the particle

filtering method was investigated by visual inspection. In most combinations of the target
and clonality measure, the parameter estimate was uninformative. Either the true parameter
value for the target simulation lay outside of even the IQR (Fig. 4.7a), or the distribution of
high RMSE and low RMSE values did not differ with respect to parameter of interest (Fig.
4.7b). Identifiability of the Clonal Expansion parameter was most thoroughly investigated.
Out of 10 targets particle filtering method was able to capture the true parameter value for: 2
of the targets using proportional clonality; 3 of the targets using the Gini coefficient; and 2
of the targets using pairwise clonality (See Table. 4.2 for estimates). Box-and-whisker plots
showing parameter estimates using each clonality metric, grouped by target are shown in the
supplementary section (Fig. A.31). Scatter plots showing point estimates for Clonal Expansion
against true parameter value for Clonal Expansion are shown in Figure (4.6. Dotted line on
the figures (with slope y = x ) represent the line of perfect prediction. Points closer to this
line are targets where predicted Clonal Expansion values were closer to the true (target) Clonal
Expansion value.
Target
1
2
3
4
5
6
7
8
9
10

True Target Clonal Expansion
2.45e-08
1.72e-01
1.98e-03
3.96e-04
2.24e-04
2.01e-03
8.45e-04
1.12e-08
6.91e-05
2.54e-02

Proportional Clonality
1.26e-01 (1.74e-03, 1.48e-01)
1.32e-03 (1.40e-07, 4.06e-05)
1.32e-03 (1.40e-07, 4.06e-05)
1.32e-03 (1.40e-07, 4.06e-05)
1.25e-01 (1.48e-03, 1.46e-01)
1.32e-03 (1.40e-07, 4.06e-05)
4.83e-02 (3.00e-07, 1.42e-02)
1.26e-01 (1.75e-03, 1.47e-01)
1.32e-03 (1.40e-07, 4.06e-05)
1.32e-03 (1.40e-07, 4.06e-05)

Particle Parameter Estimate (IQR)
Gini Coefficient
Pairwise Clonality
1.29e-01 (2.06e-03, 1.56e-01) 4.14e-04 (2.00e-07, 1.10e-04)
9.08e-03 (2.00e-07, 7.73e-05) 3.66e-04 (1.80e-07, 9.99e-05)
1.01e-01 (9.70e-06, 6.87e-02) 4.14e-04 (2.00e-07, 1.10e-04)
1.01e-01 (2.06e-03, 6.87e-02) 1.25e-01 (1.52e-03, 1.46e-01)
1.29e-01 (2.06e-03, 1.56e-01) 1.03e-01 (5.03e-05, 8.01e-02)
9.08e-03 (2.00e-07, 7.73e-05) 1.25e-01 (1.48e-03, 1.46e-01)
1.29e-01 (2.06e-03, 1.56e-01) 1.25e-01 (1.52e-03, 1.46e-01)
1.29e-01 (2.06e-03, 1.56e-01) 1.25e-01 (1.53e-03, 1.46e-01)
8.83e-03 (2.00e-07, 7.12e-05) 1.25e-01 (1.48e-03, 1.46e-01)
8.83e-03 (2.00e-07, 7.12e-05) 1.25e-01 (1.03e-03, 1.46e-01)

Table 4.2: Clonal Expansion estimate for each each target is reported for each clonality statistic.
The true target Clonal Expansion parameter is reported as well. Bolded estimates represent
estimates where the true parameter fell within the IQR
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(a) Proportional Clonality

(b) Gini Coefficient

(c) Pairwise Clonality

Figure 4.6: True (Target) Clonal Expansion values are shown on the Y axis, with point estimates (mean Clonal Expansion value) for Clonal Expansion using particle filtering method
on the X axis. Dotted line is a reference ‘perfect prediction’ line (slope y = x). Each point
represents the prediction for a given target (labeled with target number), points closer to the
prediction line are better estimates
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(a) True Clonal Expansion falls squarely out- (b) No difference in particle distribution (beside of the IQR range.
sides RMSE values)

Figure 4.7: Examples of uninformative particle filtering. Particle Filtering visualization using
same technique as 4.5. The target value for Clonal Expansion is denoted by the vertical red
line.

4.4. Discussion
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Discussion

Particle filtering yielded poor results for identifying parameter settings of target simulations
when using RMSE as a scoring measure and the median RMSE value as the threshold for
simulation parameters other than Clonal Expansion. Uninformative particle filtering scenarios
could be classified into two types of scenarios. Targets where the parameter e Targets in the
former scenario could simply represent targets for which the method would not estimate well
(e.g. the targets were outside the reasonable range for parameter estimation). A lack of difference with respect to the parameter of interest (i.e. AA br in Figure 4.7b) would suggest that
the particle filtering step did not add value to the parameter estimation. Two possible reasons
for this are: i) there was no association between the parameter of interest and the clonality
measure; or ii) the RMSE cost function was ineffective at separating particles
However, I believe the RMSE threshold value was not the issue behind these poor results.
For many of the uninformative particle filtering comparisons (where the true parameter value
fell outside of the ITR range), the parameter estimate was within the outlier region of particles
(Fig. 4.7a). Thus, changing the cutoff threshold for RMSE values (i.e. reducing to lowest 25%
RMSE values instead of 50%) would not increase the precision of the estimate. Additionally,
for other uninformative particle filtering comparisons, there was no clear separation in the
distribution of particles that are filtered and unfiltered. Fig. 4.7b shows an example of this. In
figure 4.7b, there is no distinction between the distribution of red (removed) and blue particles
(retained) along the active to active infection rate in this figure other than the RMSE values.
It is unlikely that another error metric would fix either of these inherent imperfections in the
particle filtering method.
For the former issue (poor estimation), the results would suggest that: (i) the simulation
model parameter is not suitable for parameter estimation using any of the clonality measures;
(ii) that particle filtering is not an effective method for estimating parameters; or (iii) that the
RMSE cost function is not an appropriate cost function for this use case. However, further
investigation is required into which, if any, or if all of these three are the issue. Using a
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different error metric that is reliant on the same comparison between particle clonality metric
and target clonality metric would most likely yield the same result. Possible workarounds for
fixing the latter issue (uniform RMSE scores across parameter values) may be limited as well.
Particle filtering is a method that may be able to identify the Clonal Expansion parameter in
the simclone framework under certain conditions and for certain clonality measures. It may be
possible to use the particle filtering method to identify sets of within host data that exhibit high
Clonal Expansion. Classifying the type of within host dynamic that drives the proliferation
and maintenance of the latent reservoir for individual hosts may lead to personalized therapy
responses. However, caution must be advised for applying the particle filtering method to
estimating rates of infection and transition, especially in real world data. The particle filtering
method shown here is applied to a simplistic simulation framework with many assumptions.
There is a high amount of ‘noise’ in the data due to the complexity of the simulation pipeline.
There are many moving parts in the simulation pipeline, with the added difficulty that parameter
identification is a moving target. The particle filtering results here would suggest that the goal
of the particle filtering method should drive the choice for error metric and clonality metric.
For situations where there is a non-uniform distribution of RMSE values across a parameter
range, the RMSE error metric with the Gini clonality metric could be a good starting point for
tuning a specific particle filtering method.

Chapter 5
Concluding remarks
The simclone framework can be used to simulate various scenarios of within host pathogen
dynamics. It is a flexible pipeline that can be modified to test more complex scenarios. These
complex scenarios are difficult to study in vivo for ethical and practical reasons. Retaining a
study population for the timescale at which the latent reservoir changes at is difficult. Anatomic
compartments that provide location for low level HIV-1 replication, and/or proliferation of
the latent reservoir remain hard to sample. On the practical side, it is remains expensive to
extensively sample the latent reservoir. The half-life of cells in the latent reservoir is estimated
to be approximately 44 months, translating to a natural decay timeline of over 70 years (Crooks
et al., 2015; Finzi et al., 1997a; Siliciano et al., 2003). In addition, due to the relatively low
number circulating latent reservoir cells to uninfected cells, large blood draws are required
for participants. Combination of long blood draws and lengthy timelines, make longitudinal
studies impractical. Longitudinal studies that track the latent reservoir in vivo or in vitro are
able to capture informative stop-restart ART scenarios, but these analyses are typically done
retrospectively and have many caveats. Some examples of limitations to these longitudinal
studies include: distinct clinical experiments between studies used in meta-analyses (Borges et
al., 2018; Gwadz et al., 2021); recency bias for drug adherence or behavioural studies (Gwadz
et al., 2021); and lack of verifiable data, for example prescription data used as a stand-in for
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drug adherence (Reed et al., 2021). Therefore, simulations would remain a suitable alternative
method, or at least a useful supplement to study within host HIV-1 dynamics.
Simulations provide granular data, and in particular, unlimited snapshots in time. For example, simclone pipeline captures cell level transmission and transition, data that could never
be captured when studying the latent reservoir in vivo. Simulations allow us to control rates
of transmission and transition, allowing us to understand the role each rate plays in creating
genetic diversity in the latent reservoir. An example hypothesis that could be tested is: what
effect does increasing rates of active to active transmission have on the clonality of latent reservoir; and what would happen if ART was started, then halted in this system. These can be
useful for modelling and understanding complex systems that are poorly understood, like the
HIV-1 latent reservoir. Simclone is a robust framework, however as with any other simulations,
there are limitations that can be addressed in future work. For one, the lack of anatomical
compartments (i.e. circulating CD4+ cells in peripheral blood vs. CD4+ cells in lymph nodes);
and different types of cells with unique rates of transmission and transition (i.e. Gut-Associated
Lymphoid Tissues that have low level HIV-1 replication (Thompson et al., 2017).
The simclone framework as described here is a starting point, and can already be used for
downstream analyses. Increasing the complexity of the system will only add to the usefulness
of this tool. It can be expanded to include multiple strain competition, anatomical compartments with differing within host dynamic interactions, and different models of nucleotide evolution can be selected. Increasing the complexity of the simclone framework would allow novel
hypotheses to be tested, as described previously. Some possible scenarios for future evaluation
using the simclone framework include: effect of ART cessation and restart after a viral rebound
on the latent reservoir (Borges et al., 2018); effect of low level HIV-1 replication and infection
in drug sanctuary sites (Thompson et al., 2017); and effect of HIV-1 ART initiation timing on
the latent reservoir (Brodin et al., 2016; Chavez et al., 2015). On the other hand, users should
be cautious about increasing the complexity of the tool. The simclone framework already has
a high number of parameters. Parameterizing the model to produce rational outcomes was
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already difficult for the simclone framework. Creating additional definable parameters to increase model complexity will make this process more difficult. The trade-off for simulations
that could reveal novel insights may be a narrow range of simulation parameter values. In summary, the simclone framework provides a robust simulation pipeline for measuring the within
host dynamics of the HIV-1, and can be used as the foundational pieces for further simulation
work.
The analysis of clonality measures in Chapter 3 spoke to the shortcomings of the widely
used proportional clonality measure (von Stockenstrom et al., 2015; Wagner et al., 2014), and
the proposed Gini coefficient (Sadras and Bongiovanni, 2004; Thapa et al., 2015). As discussed
in Chapter 3, there were frequent collisions in clonality scores for differing genetic population
structures for the proportional clonality measure and the Gini coefficient. Collisions occur
when two population structures are given the same clonality score. This happened more frequently when using the Gini Coefficient (due to the effect of diminishing unique groups), and
the proportional clonality score (due to low number of possible scores). Collisions are especially problematic when the distribution of genetic sequences are vastly different (i.e. proportional clonality score for population a [3,2,1] = 0.83; and for population b [5,1] = 0.83.
Collisions are unideal when using clonality measures because it conflates scenarios in further
analyses. This compounds the loss of information caused by having low numbers of possible
clonality outcomes (as in the case of proportional clonality). The Gini coefficient in particular
was not effective for measuring clonality in diminishing groups. Gini coefficient did not respond to increasing heterogeneity in a directional fashion - especially in situations where the
number of unique sequences are low. This limits the usefulness of the Gini Coefficient for
HIV-1 latent reservoir research. There are situations where there is high homogeneity in samples (Feder et al., 2016; Wolinsky et al., 1992; Yeh et al., 2021), especially when the sampling
fraction is low. Gini coefficient was flawed, and caution is advised when using Gini coefficient
to describe genetic diversity in populations with high homogeneity.
The presence of identical sequences has been interpreted in previous studies as an indication
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of clonal expansion (Bosque et al., 2011, Douek et al., 2002, Maldarelli et al., 2014). However,
my simulations showed high measures of clonality (regardless of clonality measure) are not
necessarily the result of clonal expansions. Two identical sequences that shared ancestry in
the simulation were not necessarily identical due to clonal expansion. Instead, these simulated
sequences could be identical if by chance if there was no mutations accumulated between the
two sequences since their descent from a common ancestor (prior to their respective integration
events). This mirrors research by various others (Lorenzi et al., 2016, Maldarelli et al., 2014)
who have shown that sequencing integration sites are better indicators of clonal expansion. The
findings shown here re-iterate this paradigm and support the use of sequencing integration sites
to measure clonal expansion in the latent reservoir.
Clonality has been used in other domains to characterize biological processes. For example, in cancer research, clonality is used to identify driver mutations (Martincorena, 2019,
Biermann et al., 2018, McGranahan et al., 2015). Driver mutations are mutations that drive abnormal cellular proliferation, and thus tumourgenesis. These mutations are usually identified
by observing large numbers of identical cells with excessive mutations clustered around or in
a particular region. In McGranahan et al., 2015, the authors attempted to identify actionable
driver mutations using clonality metrics. In their research, the authors used the proportional
clonality metric to describe the distribution of mutations a pan-cancer dataset. The findings
here suggest that information about the presence and diversity of sub-clonal groups may be
lost. The pairwise clonality metric could be applied in research such as the above to provide
more information about the true genetic distribution of the population than the often using proportional clonality score. Identifying driver mutations in cancers is just one avenue of research
where reductive clonality metrics are used. There are other research topics beyond driver mutations in cancer and HIV-1 where clonality cited as an indicator for an underlying event. Others
include: immunology research - T-cell antigen response dynamics (Chiffelle et al., 2020);and
ecology research - organism genetic diversity (Hughes and Stachowicz, 2009), and the relationship between carbon cycling and clonality (Cornelissen et al., 2014). The results found
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here indicate more care needs to be taken when selecting the correct clonality measure for a
particular analysis.
There is potential for the particle filtering method described in this work to be applied with
a narrow scope. The particle filtering method for parameter estimation can only be applied
to parameter-target combinations that have a non-uniform distribution with regard to RMSE
values. Estimating the true value of the clonal expansion parameter may be possible with this
technique. The RMSE cost function may not have been an appropriate cost function for this
technique. The RMSE cost function was only able to predict clonal expansion in a small subset
of cases for clonal expansion (3/10 targets). When visually inspecting the filtered particles
using the median RMSE score as a threshold, there did not appear to be a significance difference
for most parameters based on filtered status. This suggests two possibilities; i) the parameters
(excluding clonal expansion) were unresponsive to changes in clonality metric - unlikely, as
multivariate GLM results showed significance; or ii) the RMSE cost function did not accurately
penalize uninformative particles. A different approach to establishing likelihood functions can
be pursued, including incorporating the Bayesian likelihood framework to the particle filtering
(Park et al., 2021; Rasmussen et al., 2011). In future work, this parameter estimation technique
could be used to estimate the degree to which clonal expansion is responsible for an individual’s
latent reservoir. Clonality metrics would be extracted from an individual’s latent reservoir
sequence data. Simclone simulations would be created, using the real-world clonality metrics
as the target. Parameter estimates would be calculated using parameters that were most similar
to the target. These parameter estimates could provide information about about an individual’s
HIV-1 infection, and would add to our understanding of the latent reservoir as a whole. This
knowledge could help in many active areas of HIV-1 research including therapy and prevention.
In addition, there is potential to use this particle filtering method to identify parameters that are
non-linearly associated with clonality measures. Visualizing these trends, while reducing the
amount of variation by filtering the particles could provide insights into responsive variables.
This would be particularly useful if the simclone framework is expanded to test more complex
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scenarios. Particle filtering as described here is not ineffective, however opens the door to many
more possibilities.
Using the simclone framework I have created, I have shown pitfalls of the proportional
clonality measure that is widely used; the Gini coefficient that has been suggested for describing genetic population diversity; and have proposed a new pairwise clonality statistic with more
desirable statistical properties. Analysis of the clonality measures could apply to other research
domains, including cancer research. Further, I have described a particle filtering technique that
could be used to visually identify non-linear trends, and further used under stringent conditions
to estimate parameter values.

Appendix A
Supplementary

Simulation Parameter
(Intercept)
Initial Active-type Population
Initial Latent-type Population
Initial Replenishment Population
Active-to-Active Transmission
Active-to-Latent Transmission
Clonal Expansion
Active-to-Latent Transition
Latent-to-Active Transition
Active Death Rate
Latent Death Rate
Active Replenishment
Latent Replenishment

Proportional Clonality
Gini Coefficient
Coefficient Estimate
p
Coefficient Estimate
p
2.73
0.299
6.70e-01
0.494
6.46e-06
0.612
4.45e-07
0.917
1.64e-06
0.986
-5.35e-05
0.169
-8.63e-05
0.685
5.28e-05
0.539
1.55e+04
0.262
-1.27e+04
0.006
-6.57e+04
0.537
2.40e+04
0.518
4.12
0.324
-2.34
0.0001
-1.66
0.999
5.09e+02
0.195
8.25e+03
0.930
2.11e+04
0.544
1.27
0.903
-4.79e+01
0.214
2.65e+01
0.800
-1.36e+01
0.727
-2.22e+04
0.857
2.84e+04
0.548
3.60e+04
0.690
2.42e+03
0.945

Pairwise Clonality
Coefficient Estimate
p
2.48
<2e-16
-2.70e-06
<2e-16
-6.22e-06
<2e-16
-1.77e-04
<2e-16
9.53e+03
<2e-16
-5.87e+04
<2e-16
4.89
<2e-16
-7.98e+02
<2e-16
-1.32e+03
<2e-16
4.27e+01
<2e-16
-1.31e+01
<2e-16
-8.40e+03
<2e-16
-3.39e+04
<2e-16

Table A.1: Coefficient estimates and p scores are reported for GLM results. All parameters
were varied. The 3 clonality statistics were calculated from the same set of genetic sequences.
Bolded Coefficient values denote p ≤ 0.05
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InitialConditions :
o r i g i n T i m e : 10
size :
A c t i v e t y p e : 7500
L a t e n t t y p e : 5000
R e p l e n i s h t y p e : 20000
Death type : 0
indexType : A c t i v e t y p e

CompartmentTypes :
’ Active type ’ :
branching . r a t e s :
1 0 : ( A c t i v e t y p e = 0 . 0 0 0 4 3 , L a t e n t t y p e = 2 . 5 7 e −05 , R e p l e n i s h t y p e = 0 . 0 , D e a t h t y p e = 0 . 0 )
# No i n f e c t i o n o f D e a t h t y p e c o m p a r t m e n t
5:

( Active type = 0.0 , L a t e n t t y p e= 0.0 , Replenish type= 0.0 , Death type= 0 . 0 )

#No more a c t i v e i n f e c t i o n
t r a n s i t i o n . r a t e s : ( A c t i v e t y p e = 0 . 0 , L a t e n t t y p e = 5 e −05 , R e p l e n i s h t y p e = 0 . 0 , D e a t h t y p e = 0 . 0 1 )
coalescent . r a t e : 1.5
’ Latent type ’ :
b r a n c h i n g . r a t e s : ( A c t i v e t y p e =0 , L a t e n t t y p e = 1 . 6 6 e −06 , R e p l e n i s h t y p e = 0 . 0 , D e a t h t y p e = 0 . 0 )
# c o n s t a n t re − i n f e c t i o n
t r a n s i t i o n . r a t e s : ( A c t i v e t y p e =5e −05 , L a t e n t t y p e = 0 . 0 , R e p l e n i s h t y p e = 0 . 0 , D e a t h t y p e = 0 . 0 1 )
coalescent . r a t e : 1.5
’ Replenish type ’ :
b r a n c h i n g . r a t e s : ( A c t i v e t y p e =0 , L a t e n t t y p e =0 , R e p l e n i s h t y p e = 0 . 0 , D e a t h t y p e = 0 . 0 )
transition . rates :
1 0 : ( A c t i v e t y p e =0 , L a t e n t t y p e =0 , R e p l e n i s h t y p e = 0 . 0 , D e a t h t y p e = 0 . 0 )
5 : ( A c t i v e t y p e = 1 . 2 5 e −02 , L a t e n t t y p e = 1 . 2 5 e −02 , R e p l e n i s h t y p e = 0 . 0 , D e a t h t y p e = 0 . 0 )
’ Death type ’ :
b r a n c h i n g . r a t e s : ( A c t i v e t y p e =0 , L a t e n t t y p e =0 , R e p l e n i s h t y p e = 0 . 0 , D e a t h t y p e = 0 . 0 )
t r a n s i t i o n . r a t e s : ( A c t i v e t y p e =0 , L a t e n t t y p e =0 , R e p l e n i s h t y p e = 0 . 0 , D e a t h t y p e = 0 . 0 )
C o m pa r t m e n ts :
’ Activecomp ’ :
type : Active type
r e p l i c a t e s : 20
’ Latentcomp ’ :
type : Latent type
r e p l i c a t e s : 20
Lineages :
’A ’ :
sampling . time : 0
l o c a t i o n : Activecomp
replicates : 1
’B ’ :
sampling . time : 0
l o c a t i o n : Latentcomp
replicates : 1

Listing A.1: Sample YAML simclone specification file
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Figure A.1: Particle filtering parameter estimation for clonal expansion for target 1 using proportional clonality

Figure A.2: Particle filtering parameter estimation for clonal expansion for target 2 using proportional clonality

Figure A.3: Particle filtering parameter estimation for clonal expansion for target 3 using proportional clonality
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Figure A.4: Particle filtering parameter estimation for clonal expansion for target 4 using proportional clonality

Figure A.5: Particle filtering parameter estimation for clonal expansion for target 5 using proportional clonality

Figure A.6: Particle filtering parameter estimation for clonal expansion for target 6 using proportional clonality
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Figure A.7: Particle filtering parameter estimation for clonal expansion for target 7 using proportional clonality

Figure A.8: Particle filtering parameter estimation for clonal expansion for target 8 using proportional clonality

Figure A.9: Particle filtering parameter estimation for clonal expansion for target 9 using proportional clonality
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Figure A.10: Particle filtering parameter estimation for clonal expansion for target 10 using
proportional clonality

Figure A.11: Particle filtering parameter estimation for clonal expansion for target 1 using Gini
Coefficient

Figure A.12: Particle filtering parameter estimation for clonal expansion for target 2 using Gini
Coefficient
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Figure A.13: Particle filtering parameter estimation for clonal expansion for target 3 using Gini
Coefficient

Figure A.14: Particle filtering parameter estimation for clonal expansion for target 4 using Gini
Coefficient

Figure A.15: Particle filtering parameter estimation for clonal expansion for target 5 using Gini
Coefficient
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Figure A.16: Particle filtering parameter estimation for clonal expansion for target 6 using Gini
Coefficient

Figure A.17: Particle filtering parameter estimation for clonal expansion for target 7 using Gini
Coefficient

Figure A.18: Particle filtering parameter estimation for clonal expansion for target 8 using Gini
Coefficient
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Figure A.19: Particle filtering parameter estimation for clonal expansion for target 9 using Gini
Coefficient

Figure A.20: Particle filtering parameter estimation for clonal expansion for target 10 using
Gini Coefficient

Figure A.21: Particle filtering parameter estimation for clonal expansion for target 1 using
pairwise clonality
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Figure A.22: Particle filtering parameter estimation for clonal expansion for target 2 using
pairwise clonality

Figure A.23: Particle filtering parameter estimation for clonal expansion for target 3 using
pairwise clonality

Figure A.24: Particle filtering parameter estimation for clonal expansion for target 4 using
pairwise clonality

83

Figure A.25: Particle filtering parameter estimation for clonal expansion for target 5 using
pairwise clonality

Figure A.26: Particle filtering parameter estimation for clonal expansion for target 6 using
pairwise clonality

Figure A.27: Particle filtering parameter estimation for clonal expansion for target 7 using
pairwise clonality

84

Chapter A. Supplementary

Figure A.28: Particle filtering parameter estimation for clonal expansion for target 8 using
pairwise clonality

Figure A.29: Particle filtering parameter estimation for clonal expansion for target 9 using
pairwise clonality

Figure A.30: Particle filtering parameter estimation for clonal expansion for target 10 using
pairwise clonality
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(a) Clonal Expansion Estimates for Target 1

(b) Clonal Expansion Estimates for Target 2

(c) Clonal Expansion Estimates for Target 3

(d) Clonal Expansion Estimates for Target 4

(e) Clonal Expansion Estimates for Target 5

(f) Clonal Expansion Estimates for Target 6

(g) Clonal Expansion Estimates for Target 7

(h) Clonal Expansion Estimates for Target 8
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(i) Clonal Expansion Estimates for Target 9

Chapter A. Supplementary

(j) Clonal Expansion Estimates for Target 10

Figure A.31: Clonal expansion estimates for all targets by clonality statistic used. Dashed
vertical line represents true clonal expansion value. Parameter estimate lands within IQR using
the Gini Coefficient for Targets 4, 6, and 10 (d, f, and j respectively). Parameter lands within
IQR using proportional and pairwise clonality for Targets 7, and 10 (g, and j respectively)
(cont.)
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[ TYPE ] NUCLEOTIDE 1
[MODEL]

modelname

[ s u b m o d e l ] JC
[ TREE ] t r e e n a m e ( ( ( ( ( ( L a t e n t c o m p 8 3
( ( ( ( ( ( ( ( Latentcomp 91

( ( ( ( ( ( ( ( ( ( ( ( Latentcomp 11
( ( ( Latentcomp 92

B 1 : 0 . 0 ) : 0 . 0 ) : 4 . 9 e10 − 6 ) : 1 . 1 e10 − 6 ) : 1 . 2 6 e10 −8 ,

B 1 : 0 . 0 ) : 0 . 0 ) : 3 . 2 e10 − 5 ) : 1 . 4 e10 − 9 ) : e10 − 3 ) : 2 . 5 e10 −6 ,
B 1 : 0 . 0 ) : 0 . 0 ) : 7 . 2 e10 − 8 ) : 4 . 7 e10 − 6 ) : 8 . 3 e10 −6 ,

B 1 : 0 . 0 ) : 0 . 0 ) : 4 . 5 e10 − 7 ) : 4 . 4 e10 − 9 ) : 0 . 0 ) : 2 . 0 e10 −8)

: 1 . 0 e10 − 9 ) : 7 . 8 e10 −6 ,
( ( ( Activecomp 99

A 1 : 1 . 9 e10 − 3 ) : 4 . 2 e10 − 3 ) : 4 . 4 e10 − 8 ) : 4 . 8 e10 − 8 ) : 0 . 0 ) : 7 . 8 e10 − 6 ) : 4 . 7 e10 −4)

: 3 . 6 e10 − 9 ) : 0 . 0 ) : 3 . 8 e10 − 6 , ( ( ( ( ( L a t e n t c o m p 8 1

B 1 : 0 . 0 ) : 0 . 0 ) : 3 . 6 e10 −5)

: 5 . 8 e10 − 1 0 ) : 7 . 2 e10 − 6 ) ) ) ) ) ;
[ PARTITIONS ] p a r t i t i o n n a m e
[ t r e e n a m e modelname / s i m c l o n e / NC 001802 . 1 . f a ]
[EVOLVE] p a r t i t i o n n a m e 1 o u t p u t n a m e

Listing A.2: Sample INDELible control file
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Andries, K., Moeremans, M., De Raeymaeker, M., & et al. (1996). Virological and immunological analysis of a triple combination pilot study with loviride, lamivudine and
zidovudine in hiv-1-infected patients. AIDS, 10(5). https://doi.org/10.1097/00002030199605000-00001
Stengel, R. F. (2008). Mutation and control of the human immunodeficiency virus. Mathematical Biosciences, 213(2), 93–102. https://doi.org/10.1016/j.mbs.2008.03.002
Sundquist, W. I., & Krausslich, H.-G. (2012). Hiv-1 assembly, budding, and maturation. Cold
Spring Harbor Perspectives in Medicine, 2(7). https://doi.org/10.1101/cshperspect.
a006924

BIBLIOGRAPHY

107

Takeuchi, Y., Nagumo, T., & Hoshino, H. (1988). Low fidelity of cell-free dna synthesis by
reverse transcriptase of human immunodeficiency virus. Journal of Virology, 62(10),
3900–3902. https://doi.org/10.1128/jvi.62.10.3900-3902.1988
Taswell, C. (1984). Limiting dilution assays for the determination of immunocompetent cell
frequencies. iii. validity tests for the single-hit poisson model. Journal of Immunological Methods, 72(1), 29–40. https://doi.org/10.1016/0022-1759(84)90430-7
Telesnitsky, A. (2010). Retroviruses: Molecular biology, genomics and pathogenesis. Future
Virology, 5(5), 539–543. https://doi.org/10.2217/fvl.10.43
Thapa, D. R., Tonikian, R., Sun, C., Liu, M., Dearth, A., Petri, M., Pepin, F., Emerson, R. O., &
Reanger, A. (2015). Longitudinal analysis of peripheral blood t cell receptor diversity
in patients with systemic lupus erythematosus by next-generation sequencing. Arthritis
Research & Therapy, 17(1). https://doi.org/10.1186/s13075-015-0655-9
Thompson, C. G., Gay, C. L., & Kashuba, A. D. (2017). Hiv persistence in gut-associated
lymphoid tissues: Pharmacological challenges and opportunities. AIDS Research and
Human Retroviruses, 33(6), 513–523. https://doi.org/10.1089/aid.2016.0253
Tomezsko, P. J., Corbin, V. D., Gupta, P., Swaminathan, H., Glasgow, M., Persad, S., Edwards,
M. D., Mcintosh, L., Papenfuss, A. T., Emery, A., & et al. (2020). Determination of
rna structural diversity and its role in hiv-1 rna splicing. Nature, 582(7812), 438–442.
https://doi.org/10.1038/s41586-020-2253-5
UNAIDS. (2021). Global hiv & aids statistics - fact sheet. https : / / www . unaids . org / en /
resources/fact-sheet
von Stockenstrom, S., Odevall, L., Lee, E., Sinclair, E., Bacchetti, P., Killian, M., Epling, L.,
Shao, W., Hoh, R., Ho, T., & et al. (2015). Longitudinal genetic characterization reveals
that cell proliferation maintains a persistent hiv type 1 dna pool during effective hiv
therapy. Journal of Infectious Diseases, 212(4), 596–607. https : / / doi . org / 10 . 1093 /
infdis/jiv092

108

BIBLIOGRAPHY

Vrancken, B., Rambaut, A., Suchard, M. A., Drummond, A., Baele, G., Derdelinckx, I., Van
Wijngaerden, E., Vandamme, A.-M., Van Laethem, K., Lemey, P., & et al. (2014).
The genealogical population dynamics of hiv-1 in a large transmission chain: Bridging within and among host evolutionary rates. PLoS Computational Biology, 10(4).
https://doi.org/10.1371/journal.pcbi.1003505
Wagner, T. A., McLaughlin, S., Garg, K., Cheung, C. Y., Larsen, B. B., Styrchak, S., Huang,
H. C., Edlefsen, P. T., Mullins, J. I., Frenkel, L. M., & et al. (2014). Proliferation of
cells with hiv integrated into cancer genes contributes to persistent infection. Science,
345(6196), 570–573. https://doi.org/10.1126/science.1256304
Wang, S., Li, H., Lian, Z., & Deng, S. (2022). The role of rna modification in hiv-1 infection.
International Journal of Molecular Sciences, 23(14), 7571. https://doi.org/10.3390/
ijms23147571
Wang, Z., Simonetti, F. R., Siliciano, R. F., & Laird, G. M. (2018). Measuring replication competent hiv-1: Advances and challenges in defining the latent reservoir. Retrovirology,
15(1). https://doi.org/10.1186/s12977-018-0404-7
Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D.,
Bonhoeffer, S., Nowak, M. A., Hahn, B. H., & et al. (1995). Viral dynamics in human
immunodeficiency virus type 1 infection. Nature, 373(6510), 117–122. https://doi.org/
10.1038/373117a0
Wolinsky, S. M., Wike, C. M., Korber, B. T., Hutto, C., Parks, W. P., Rosenblum, L. L., Kunstman, K. J., Furtado, M. R., & Muñoz, J. L. (1992). Selective transmission of human
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